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Abstract:  
Isothiourea HBTM-2.1 promotes the catalytic asymmetric -functionalization of 3-alkenoic acids through 
formal [2+2] cycloadditions with N-tosyl aldimines and formal [4+2] cycloadditions with either 4-
aryltrifluoromethyl enones or N-aryl-N-aroyl diazenes, providing useful synthetic building blocks in good 
yield and with excellent enantiocontrol (up to >99% ee). Stereodefined products are amenable to further 
synthetic elaboration through manipulation of the olefinic functionality. 
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Introduction 
The organocatalytic generation of dienolates or their dienamine equivalents is an increasingly popular area 
of research.
1
 These intermediates have powerful synthetic potential due to their ability to react regio- and 
enantioselectively through either - or -positions, allowing rapid access to diverse molecular scaffolds. In 
particular, recent research has demonstrated the ability of ammonium and azolium dienolates to participate 
in asymmetric transformations.
2-11
 For example, Peters
2
 and Ye
3
 have accessed cinchona alkaloid and 
norephedrine derived C1-ammonium dienolates from ,-unsaturated acid chloride starting materials and 
applied these towards the synthesis of a range of stereodefined products (Scheme 1). C1-ammonium 
dienolate 1 may form either via initial dehydrohalogenation to form vinyl ketene 2 which is intercepted by 
the Lewis base, or from initial attack of the Lewis base to form ,-acyl ammonium 3 followed by -
deprotonation. To the best of our knowledge, all catalytically generated ,-disubstituted C1-ammonium 
dienolates documented in the literature react to give-functionalized products. 
 
Scheme 1: Generation and utility of C1-ammonium dienolates.  
 
C1-azolium dienolates have also received considerable attention within the past two years. For example, 
Ye demonstrated that ,-unsaturated acid chlorides 4, in the presence of an N-heterocyclic carbene 
(NHC) and base, afford C1-azolium dienolates 5 that react via the -centre in asymmetric formal [4+2] 
 3 
cycloadditions with 2 electrophiles (Scheme 2a).4 Chi subsequently disclosed the ability to access the 
same dienolate via both enals 6 (in presence of a stoichiometric oxidant)
5,6
 and ,-unsaturated esters 7 
(Scheme 2b,c).
7
 Alternatively, enals bearing an -bromo leaving group such as 8 have also been 
demonstrated as suitable azolium dienolate precursors (Scheme 2d).
8
 In examples a-d, each process is 
postulated to involve -deprotonation of the corresponding ,-disubstituted-,-acyl azolium 
intermediate to generate the corresponding dienolate, often depicted in both (E)- and (Z)-configurations,  
followed by -functionalization of the resulting azolium dienolate.9 Alternatively, aldehydes that contain a 
-leaving group such as 9 have been used to access C1-azolium dienolates 10 (Scheme 2e). Interestingly, 
these dienolates give -functionalization via fluorination with NFSI, and -functionalization in the formal 
[4+2] cycloaddition with diazodicarboxylates 11, affording esters 12
10
 and lactams 13
11
 respectively.  
 
Scheme 2: Generation and utility of C1-azolium dienolates. 
 
 4 
Building upon the elegant nucleophile catalysed aldol-lactonisation (NCAL) reaction developed by 
Romo,
12
 we have recently shown that isothioureas
13,14
 can generate ammonium enolates
15
 in situ from 
carboxylic acids that subsequently undergo a range of intra- and intermolecular Michael addition-
lactonization/lactamization reactions to generate stereodefined products.
16
 Although powerful, the success 
of the intermolecular processes often relies upon using arylacetic acids as starting materials,
17,18
 which 
constitutes a limitation of this organocatalytic strategy. To broaden the substrate scope of such processes, 
the use of 3-alkenoic acids would allow access to extended ammonium dienolates that could give rise to 
either - or -functionalized products in a stereodefined manner (Scheme 3). In this manuscript, a range of 
3-alkenoic acids are shown to act as suitable precursors to isothiourea derived ammonium dienolates that 
react in a variety of formal [2+2] and [4+2] cycloadditions. In contrast to previously accessed C1-
ammonium dienolates formed via -deprotonation, these ammonium dienolates are formed via -
deprotonation and provide exclusively -functionalized products. This strategy introduces an additional 
exocyclic olefin functional handle, allowing for further product functionalization into useful synthetic 
building blocks.
 
 
Scheme 3: Proposed asymmetric transformations of 3-alkenoic acids via either - or -functionalization. 
Results and Discussion 
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Generation of isothiourea derived ammonium dienolates and reaction with 2 electrophiles 
Initial studies probed the ability of isothioureas to generate an ammonium dienolate from a 3-alkenoic 
acid, with subsequent reaction with a reactive 2 component used to test if - or -selectivity is observed. 
Encouraged by Ye’s report demonstrating diazadicarboxylates as suitable reaction partners with C1-
ammonium dienolates,
3a
 along with both Ye and Chi who showed that trifluoromethyl ketones are suitable 
partners in [4+2] cycloadditions with C1-azolium dienolates,
4,5
 these 2 components were evaluated. 
Following our report in the previous manuscript we also evaluated N-tosyl aldimines 2 electrophiles.19 
Using 3-methylbut-3-enoic acid 14 or 2-(cyclopent-1-en-1-yl)acetic acid 15 with pivaloyl chloride as 
activating agent, achiral DHPB 17 (3,4-dihydro-2H-pyrimido[2,1-b]benzothiazole) as catalyst and 
trifluoromethyl ketone 18 as the 2 electrophile,20 no distinguishable cycloaddition products were 
observed (Table 1). Under the same reaction conditions, (E)-4-phenylbut-3-enoic acid 16 reacted with 
trifluoromethyl ketone 18, giving solely the [2+2] cycloaddition product -lactone 21 (60:40 dr anti:syn) 
derived from -functionalization21 in 71% combined yield whilst reaction with N-tosyl aldimine 19 gave 
-lactam 22 (83:17 dr anti:syn) in 68% yield (anti diastereoisomer).22-24 Unfortunately, diazodicarboxylate 
20 proved incompatible with this system giving no distinguishable product despite full consumption of 20.  
 
Entry Carboxylic Acid Electrophile Product (major) dr
a 
(anti:syn) Yield
b 
(% anti,syn) 
1 
  
None N/A N/A 
2 
  
None N/A N/A 
 6 
3 
  
 
60:40 43,29 
4 
  
 
83:17 68,- 
5 
  
None N/A N/A 
Table 1: Initial studies:
 a
 Determined by 
1
H NMR spectroscopic analysis of the crude reaction mixture; 
b
 
Isolated yield (≥95:5 dr). 
 
Encouraged by the promising diastereoselectivities observed in the reaction with N-tosyl aldimine 19, 
further optimization studies focused upon finding a suitable asymmetric variant. Screening of a range of 
isothiourea catalysts and C(4)-substituted alkenoic acids revealed that chiral isothiourea HBTM-2.1 23 
efficiently promotes the formal [2+2] cycloaddition of (E)-pent-3-enoic acid 24 and imine 25 at rt, 
affording -lactam 26 in moderate diastereoselectivity (68:32 dr anti:syn), with each separable 
diastereoisomer isolated in good yield (53% anti, 27% syn) and enantioselectivity (anti 79% ee, syn 72% 
ee) (Table 2). Lowering the temperature to −78 °C resulted in similar diastereoselectivity (71:29 dr 
anti:syn), but with each separable diastereoisomer formed in excellent enantioselectivity (anti 97% ee, syn 
>99% ee).
25 
 
 
Entry T (°C) dr
a 
(anti:syn) Yield
b 
(% anti,syn) ee
c
 (% anti,syn) 
 7 
1 23 68:32 53,27 79,72 
2 −78 71:29 53,11 97,>99 
Table 2: Formal [2+2] cycloaddition using N-tosyl aldimine 25:
 a
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture; 
b
 Isolated yield (≥95:5 dr); c Determined by chiral HPLC analysis. 
 
The absolute configuration of syn--lactam 27 was confirmed unambiguously by X-ray crystallography as 
(3S,4S),
26
 while that of the anti--lactam 26 was confirmed by an epimerization experiment (Scheme 4). 
Treatment of syn--lactam (3S,4S)-27 (>99:1 dr, >99% ee) using iPr2NEt at rt for 16 h gave a (58:42 
syn:anti) mixture comprising of syn--lactam (3S,4S)-27 (96% ee) and anti--lactam (3R,4S)-26 (96% ee) 
as determined by Chiral HPLC. The absolute configuration of the anti--lactam formed by epimerization 
is opposite to that observed experimentally in the catalytic process. Assuming epimerization occurs solely 
at C(3), this allows the absolute configuration of the anti--lactam formed in Table 2 to be assigned 
(3S,4R).
27
 
 
Scheme 4: Epimerization experiment; 
a
 Determined by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture; 
b
 Determined by HPLC analysis. 
 
The generality of this protocol was next investigated by variation of both the acid and aldimine 
components (Table 3). Within the aldimine, electron-donating and withdrawing groups can be 
incorporated provided the reactions are carried out at rt.
28
 4-OMe Substituted -lactam 28 is formed in 
good diastereo- and enantioselectivity, whilst incorporation of the 4-CF3 group results in a significant 
reduction in enantioselectivity (44% ee). Heteroaryl substituents (2-furyl) and extended aromatics (2-
naphthyl) are tolerated within the aldimine, giving -lactams 30 and 31 in modest diastereoselectivity with 
 8 
the major (anti) diastereoisomer formed in excellent ee (95% and 97% respectively). In cases where the 
minor (syn) diastereoisomer can be isolated, it is always formed in excellent enantioselectivity (>96% ee). 
Both the 4-position substituent and the configuration within the acid component can also be varied; for 
example (E)-4-ethyl, (E)-4-isopropyl and (E)-4-benzyl alkenoic acids give the corresponding -lactams 
32-34 in high yields and good diastereo- and enantioselectivities. Finally, (Z)-pent-3-enoic acid was used 
as a starting material, giving the usual -functionalization under the reaction conditions, but generating -
lactam 35 with negligible diastereoselectivity at −78 °C (43:57 dr, anti:syn), despite both diastereoisomers 
being formed in exquisite enantioselectivity (>99% ee).
29  
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Table 3: Formal [2+2] cycloaddition scope.
 a
 Determined by 
1
H NMR spectroscopic analysis of the crude 
reaction mixture; 
b
 Isolated yield (≥95:5 dr); c Determined by chiral HPLC analysis; d Isolated yield (92:8 
dr);
 e
 Isolated yield (88:12 dr); 
  
[4+2] cycloadditions of isothiourea derived ammonium dienolates with 4 electrophiles 
Having established the propensity of these ammonium dienolates to react at the -position with 2 
electrophiles, their ability to partake in formal [4+2] cycloadditions with electron deficient 4 Michael 
acceptors was investigated. HBTM-2.1 23 efficiently catalyzes the reaction between (E)-pent-3-enoic and 
(E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one in only 5 minutes at rt, giving -lactone 36 in 80% yield with 
good diastereoselectivity (88:12 dr) and excellent enantioselectivity (96% ee).
30-32
 The reaction proceeds 
efficiently using (E)-3-hexenoic acid, giving -lactone 37, although when using (E)-styrylacetic acid the 
reaction has to be carried out at −78 °C to prevent product decomposition and gives the major 
diastereoisomer of -lactone 38 in reduced enantioselectivity (60% ee). Heteroaryl and 4-bromophenyl 
substituted trifluoromethyl enones are also tolerated giving -lactones 39 and 40 in good yields and high 
diastereo- and enantioselectivity (Table 4). 
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Table 4: Formal [4+2] cycloadditions with 4-aryltrifluoromethyl enones; 
a
 Determined by 
1
H NMR 
spectroscopic analysis of the crude reaction mixture; 
b
 Isolated yield (88:12 dr); 
c
 Determined by HPLC 
analysis;
 d
 Isolated yield (93:7 dr); 
e
 Isolated yield (≥95:5 dr); f Isolated yield (84:16 dr). 
 
The generality of this asymmetric Michael addition-lactonization process was next investigated using N-
aryl-N-aroyldiazenes as Michael acceptors, followed by in situ ring opening of the intermediate 1,3,4-
oxadiazin-6-one formal [4+2] cycloaddition adduct with MeOH. Examples including the use of 3-alkenoic 
acids bearing 4-alkyl (Me, Et, iPr), 4-benzyl and 4-phenyl substituents, in addition to (E)- and (Z)-alkene 
configurations are all readily incorporated giving, after in situ ring-opening with methanol,
33
 a range of 
hydrazides 41-46 in high yields (71-85 %) and excellent enantioselectivity (91-99 % ee) (Table 5).
34,35
 
Diazenes bearing electron deficient (4-FC6H4) and heteroaryl (2-furyl) N-aroyl substituents are also 
tolerated giving products 47 and 48 in excellent ee. 
   
   
  
 
 
 
 
Table 5: Formal [4+2] cycloaddition/ring opening with N-aryl-N-aroyldiazenes; 
a
 Isolated yield. 
b
 
Determined by HPLC analysis. 
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Having developed a highly enantioselective route to hydrazides 41-48, their potential for further 
elaboration through functionalization of the olefin was probed. Treatment of hydrazide 41 under Upjohn 
dihydroxylation conditions, followed by acid catalysed cyclisation, gave a 70:30 mixture of separable 
diastereomeric 5-membered lactones 49 and 50 in 85% combined yield, both in 99% ee (Scheme 5).
36
 
These interesting aza-sugar derivatives structurally resemble the cyclized form of (+)-polyoxamic acid, 
indicating their potential biological significance.  
 
Scheme 5: Conversion of hydrazide 41 to lactones 49 and 50; 
a
 Determined by 
1
H NMR spectroscopic 
analysis of the crude reaction mixture; 
b
 Isolated yield (>98:2 dr); 
c
 Determined by HPLC analysis. 
 
We propose that the catalytic cycle for these transformations proceeds via initial N-acylation of HBTM-2.1 
23 with the pre-formed mixed anhydride to form the corresponding acyl ammonium ion. -Deprotonation 
generates the (Z,E)-enolate (from the (E)-alkenoic acid), which undergoes stereoselective Michael addition 
via -functionalization with electron deficient 4 Michael acceptors, followed by intramolecular 
 12 
cyclisation, to generate the corresponding heterocyclic species (Figure 1). The sense of stereoinduction in 
these transformations is consistent with our previous rationale.
16a,c
 We tentatively assign the origin of the 
observed -functionalization in these processes to preferential reaction via the assumed s-trans (Z,E)-
dienolate conformation 51, in preference to the s-cis (Z,E)-dienolate conformation 52 that is presumably 
necessary to participate in -functionalization. 
 
Figure 1: Proposed mechanism of asymmetric heterocycle formation. 
 
Conclusion: Isothiourea-mediated functionalization of 3-alkenoic acids occurs regioselectively, giving 
products derived from -functionalization of an intermediate ammonium enolate in a range of formal 
[2+2] and [4+2] cycloadditions. Formal [2+2] cycloadditions with N-tosyl aldimines proceed readily using 
HBTM-2.1 (10 mol%) with moderate diastereocontrol (up to 87:13 dr) and excellent enantiocontrol (up to 
>99% ee). Formal [4+2] cycloadditions with either 4-aryl-trifluoromethylenones or N-aryl-N-
aroyldiazenes are also catalyzed by HBTM-2.1 (1-5 mol%), with products obtained in high diastereo- and 
enantiocontrol (up to 95:5 dr, up to 99% ee). The simple, two-step elaboration of stereodefined hydrazides 
into aza-sugar analogues without erosion of enantiopurity has also been demonstrated. Current research 
 13 
from this laboratory is directed toward developing alternative applications of isothioureas in asymmetric 
catalysis. 
Experimental: 
General Information 
Reactions involving moisture sensitive reagents were carried out under an argon atmosphere using 
standard vacuum line techniques in addition to dry solvents. In these cases, all glassware used was flame 
dried and cooled under vacuum. 
For moisture sensitive reactions, solvents (THF, CH2Cl2, toluene, hexane and Et2O) were obtained 
anhydrous and purified by an alumina column. Petrol is defined as petroleum ether 40-60 °C. All other 
solvents and commercial reagents were used as supplied without further purification unless stated 
otherwise. Room temperature (rt) refers to 20−25 °C, with temperatures of 0 and −78 °C obtained using 
ice/water and CO2(s)/acetone baths, respectively. 1H NMR spectra were acquired at 300, 400, or 500 
MHz, 13C{1H} NMR spectra were acquired at 75, 100, or 125 MHz, and 19F{1H} NMR spectra were 
acquired at 282, 376, or 471 MHz. Chemical shifts are quoted in parts per million (ppm) relative to the 
residual solvent peak. Coupling constants, J, are quoted in Hertz (Hz). NMR peak assignments were 
confirmed using 2D 1H correlated spectroscopy (COSY), 2D 1H nuclear Overhauser effect spectroscopy 
(NOESY), 2D 1H−13C heteronuclear multiple-bond correlation spectroscopy (HMBC), and 2D 1H−13C 
heteronuclear single quantum coherence (HSQC) where necessary. Infrared spectra were recorded as thin 
films using an attenuated total reflectance (ATR) accessory. Mass spectrometry (m/z) data was acquired 
using electrospray ionization (ESI), electron impact (EI), chemical ionization (CI), atmospheric solids 
analysis probe (ASAP), atmospheric pressure chemical ionization (APCI), or nanospray ionization (NSI) 
using a time of flight (TOF) mass analyzer. Optical rotations were recorded with a path length of 1 dm and 
concentrations, c, are quoted in g/100 mL. All chiral high-performance liquid chromatography (HPLC) 
traces were compared with an authentic racemic trace. Racemic compounds were prepared using general 
procedure A, employing either DHPB 17 or (±)-HBTM-2.1 23 as catalyst. 
 14 
Isothiourea catalysts used 
DHPB 17, HBTM-2.1 (±)-23 and HBTM-2.1 (2S,3R)-23 were made to literature procedures.
16d 
N-tosyl aldimines used 
4-methyl-N-[(1E)-phenylmethylidene]benzene-1-sulfonamide 19, 4-methyl-N-[(1E)-4-
(bromophenyl)methylidene]benzene-1-sulfonamide 25, 4-methyl-N-[(1E)-4-
(methoxyphenyl)methylidene]benzene-1-sulfonamide 53, 4-methyl-N-[(1E)-4-
(trifluoromethylphenyl)methylidene]benzene-1-sulfonamide 54, N-[(1E)-furan-2-ylmethylidene]-4-
methylbenzene-1-sulfonamide 55 and 4-methyl-N-[(1E)-naphthalen-2-ylmethylidene]benzene-1-
sulfonamide 56 were made according to literature procedures.
37
 
Trifluoromethyl enones used 
(E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one 57, (E)-1,1,1-trifluoro-4-(4-bromophenyl)-3-buten-2-one 58 
and (E)-1,1,1-trifluoro-4-(2-thienyl)-3-buten-2-one 59 were made according to literature procedures.
16d
 
N-aryl-N-aroyldiazenes used 
(NE)-N-(phenylimino)benzamide 60, (NE)-4-fluoro-N-(phenylimino)benzamide 61 and (NE)-N-
(phenylimino)furan-2-carboxamide 62 were made according to literature procedures.
16c 
Carboxylic acids used 
(E)-4-phenylbut-3-enoic acid 16, (E)-pent-3-enoic acid 24 and (E)-hex-3-enoic acid 81 were used as 
purchased.  
3-methylbut-3-enoic acid 14 
Following a literature procedure,
38
 to a solution of 3-methylbut-3-en-1-ol (2.00 mL, 19.8 mmol) in acetone 
(100 mL) at 0 °C was added 2.68 M Jones’ reagent (10.4 mL, 27.7 mmol) and the reaction mixture was 
stirred at 0 °C for 1 h. The reaction mixture was washed with 2M NaOH and then the aqueous layer 
acidified with conc HCl and extracted with Et2O (x 3). The combined organic extracts were dried 
(MgSO4), filtered and concentrated in vacuo. The residual oil was purified by distillation to give acid 3-
 15 
methylbut-3-enoic acid 14 as a colourless oil (1.50 g, 76%); bp 88-90 °C (20 mmHg); {lit.
38
 bp 67-70 °C 
(10 mmHg)}; δH (500 MHz, CDCl3) 1.87 (3H, s, CH3), 3.11 (2H, s, CH2), 4.92 (1H, s, =CHH), 4.99 (1H, 
s, =CHH). Data are in accordance with the literature.
38 
ethyl 2-cyclopentylideneacetate 63 
Following a literature procedure,
39
 to a suspension of 60% NaH in mineral oil (1.23 g, 51.4 mmol) in Et2O 
(120 mL) at 0 °C was added ethyl 2-(diethoxyphosphoryl)acetate (10.2 mL, 51.4 mmol) and the reaction 
mixture was stirred for 5 minutes at 0 °C. A solution of cyclopentanone (4.42 mL, 50.0 mmol) in Et2O (10 
mL) was added and the reaction mixture was allowed to stir at rt for 4 h. The reaction mixture was diluted 
with water and extracted with Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Chromatographic purification (eluent Et2O:petrol 10:90) gave ethyl 2-
cyclopentylideneacetate 63 as a colourless oil (7.00 g, 91%); δH (500 MHz, CDCl3) 1.30 (3H, t, J 7.1, 
CH3), 1.68 (2H, quintet, J 6.8, CH2), 1.77 (2H, quintet, J 7.0, CH2), 2.44-2.47 (2H, m, CH2C=), 2.78-2.81 
(2H, m, CH2C=), 4.17 (2H, q, J 7.1, CH2CH3), 5.82 (1H, quintet, J 2.2, =CH). Data are in accordance with 
the literature.
39
  
ethyl 2-(cyclopent-1-en-1-yl)acetate 64 
Following a literature procedure,
40
 To a solution of DIPA (5.82 mL, 41.2 mmol) in THF (80 mL) at 0 °C 
was added 2.5 M n-BuLi (16.5 mL, 41.2 mmol) and the reaction mixture was stirred at that temperature 
for 30 minutes. The reaction mixture was cooled to −78 °C and a solution of ethyl 2-(cyclopent-1-en-1-
yl)acetate 63 (5.88 g, 38.2 mmol) in THF (25 mL) was added dropwise over 15 minutes before stirring for 
a further 20 minutes. The reaction mixture was quenched by addition of sat. aq. NH4Cl and the reaction 
mixture was warmed to rt before being poured into water and extracted with Et2O (x 3). The combined 
organic extracts were dried (MgSO4), filtered and concentrated in vacuo to give ethyl 2-(cyclopent-1-en-1-
yl)acetate 64 as a light yellow oil (5.68 g, 97%); δH (500 MHz, CDCl3) 1.29 (3H, t, J 7.1, CH3), 1.93 (2H, 
 16 
quintet, J 7.5, CH2), 2.33-2.38 (4H, m, CH2 and CH2), 3.14 (2H, s, CH2CO2Et), 4.17 (2H, q, J 7.1, 
CH2CH3), 5.55-5.57 (1H, m, =CH). Data are in accordance with the literature.
40
 
2-(cyclopent-1-en-1-yl)acetic acid 15 
Following a literature procedure,
41
 a solution of ethyl 2-(cyclopent-1-en-1-yl)acetate 64 (4.15 g, 27.0 
mmol) in 0.5 M KOH (80.8 mL, 40.4 mmol) was heated at reflux for 16 h. Once cooled to rt the reaction 
mixture was extracted with Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered and 
concentrated in vacuo. Recrystallisation from petrol gave 2-(cyclopent-1-en-1-yl)acetic acid 15 as a white 
solid (2.74 g, 59%); mp 44-46 °C; {lit.
41
 mp 48-51 °C}; δH (300 MHz, CDCl3) 1.90-2.00 (2H, m, CH2), 
2.37-2.42 (4H, m, CH2 and CH2), 3.21 (2H, s, CH2CO2H), 5.63 (1H, m, =CH). Data are in accordance 
with the literature.
41 
(E)-5-methylhex-3-enoic acid 65 
Following a literature procedure,
42 
a solution of piperidine (39.5 L, 0.40 mmol) and acetic acid (22.9 L, 
0.40 mmol) in DMSO (1 mL) was stirred at rt for 5 minutes after which time a solution of malonic acid 
(4.16 g, 40.0 mmol) and isovaleraldehyde (4.29 mL, 40.0 mmol) in DMSO (20 mL) was added. The 
reaction mixture was stirred at rt for 20 minutes and then at 100 °C for 16 h. Once cooled to rt, the 
reaction mixture was diluted with H2O and extracted with Et2O (x 3). The combined organic fractions 
were washed with H2O, dried (MgSO4), filtered and concentrated in vacuo. Chromatographic purification 
(eluent Et2O:petrol 30:70) gave (E)-5-methylhex-3-enoic acid 65 as a colourless oil (2.93 g, 57%); δH (400 
MHz, CDCl3) 0.99 (6H, d, J 6.8, CH(CH3)2), 2.26-2.34 (1H, m, C(5)H), 3.07 (2H, dt, J 6.6, 0.9, C(2)H2), 
5.47 (1H, dtd, J 15.4, 6.7, 1.1, C(3)H), 5.54-5.60 (1H, m, C(4)H). Data are in accordance with the 
literature.
42 
(E)-5-phenylpent-3-enoic acid 66
 
Following a literature procedure,
42 
a solution of piperidine (39.5 L, 0.40 mmol) and acetic acid (22.9 L, 
0.40 mmol) in DMSO (1 mL) was stirred at rt for 5 minutes after which time a solution of malonic acid 
 17 
(4.16 g, 40.0 mmol) and 3-phenylpropionaldehyde (5.28 mL, 40.0 mmol) in DMSO (20 mL) was added. 
The reaction mixture was stirred at rt for 20 minutes and then at 100 °C for 16 h. Once cooled to rt, the 
reaction mixture was diluted with H2O and extracted with Et2O (x 3). The combined organic fractions 
were washed with H2O, dried (MgSO4), filtered and concentrated in vacuo. Chromatographic purification 
(eluent Et2O:petrol 25:75) gave (E)-5-phenylpent-3-enoic acid 66
 
as a colourless oil (4.15 g, 59%); δH (400 
MHz, CDCl3) 3.13 (2H, dq, J 6.8, 1.1, C(5)H2), 3.40 (2H, d, J 6.7, C(2)H2), 5.63 (1H, dtt, J 15.3, 6.9, 1.4, 
C(3)H), 5.77 (1H, dtt, J 15.3, 6.7, 1.3, C(4)H), 7.18-7.23 (3H, m, Ar(2,6)H and Ar(4)H), 7.28-7.32 (2H, 
m, Ar(3,5)H). Data are in accordance with the literature.
43 
(Z)-pent-3-en-1-ol 67
 
Following a literature procedure,
44 
lindlar’s catalyst (5% on CaCO3, Pb poisoned, 900 mg (45 mg Pd), 
0.43 mmol) was degassed in a RB flask. Quinoline (0.72 mL, 6.04 mmol), Et2O (150 mL) and pent-3-yn-
1-ol (2.74 mL, 29.7 mmol) were added and a balloon of H2 gas was appended to the reaction flask. H2 gas 
was bubbled through the reaction mixture at rt for 20 h. The reaction mixture was filtered through Celite 
concentrated in vacuo and the residual oil was purified by distillation to give alcohol (Z)-pent-3-en-1-ol 67 
(94:6 (Z):(E)) as a colourless oil (1.64 g, 64%); bp 140-141 °C (760 mmHg); {lit.
44
 bp 140 °C (760 
mmHg)}; Data for (Z)-isomer: δH (500 MHz, CDCl3) 1.65-1.68 (3H, m, CH3), 2.32-2.37 (2H, m, C(2)H2), 
3.66 (2H, q, J 6.2, C(1)H2), 5.37-5.43 (1H, m, C(4)H), 5.62-5.68 (1H, m, C(3)H); Selected data for (E)-
isomer: δH (500 MHz, CDCl3) 1.68-1.70 (3H, m, CH3), 2.23-2.28 (2H, m, C(2)H2). Data are in accordance 
with the literature.
44
 
(Z)-pent-3-enoic acid 68 
Following a literature procedure,
44 
to K2Cr2O7 (56.1 mg, 0.19 mmol), HNO3 (343 mg, 3.81 mmol) and 
NaIO4 (8.97 g, 42.0 mmol) in H2O (25 mL) was added a solution of (Z)-pent-3-en-1-ol 67 (1.64 g, 19.1 
mmol) in MeCN (50 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 8 h followed by rt for 16 h. 
The inorganic salts were filtered and washed with Et2O. H2O was added and the reaction mixture was 
 18 
extracted with Et2O (x 3). The combined organic fractions were dried (MgSO4), filtered and concentrated 
in vacuo. The residual oil was purified by distillation to give (Z)-pent-3-enoic acid 68 (94:6 (Z):(E)) as a 
colourless oil (0.69 g, 36%); bp 100-102 °C (22 mmHg); {lit.
44
 bp 100 °C (20 mmHg)}; Data for (Z)-
isomer: δH (500 MHz, CDCl3) 1.64 (3H, dt, J 6.8, 0.8, CH3), 3.14 (2H, dd, J 7.2, 0.4, C(2)H2), 3.66 (2H, q, 
J 6.2, C(1)H2), 5.56 (1H, dtq, J 10.7, 7.1, 1.8, C(3)H), 5.66-5.73 (1H, m, C(4)H); Selected data for (E)-
isomer: δH (500 MHz, CDCl3) 1.70 (3H, dt, J 6.3, 1.3, CH3), 3.06 (2H, dt, J 6.7, 1.2, C(2)H2). Data are in 
accordance with the literature.
44
 
(E)-ethyl 3-phenylbut-2-enoate 69 
Following a literature procedure,
45 
to a suspension of 60% NaH in mineral oil (1.00 g, 41.6 mmol) in THF 
(35 mL) at 0 °C was added ethyl 2-(diethoxyphosphoryl)acetate (8.26 mL, 41.6 mmol) dropwise over 30 
minutes and the reaction mixture was stirred for 30 minutes at rt. A solution of acetophenone (4.85 mL, 
41.6 mmol) in THF (15 mL) was added dropwise and the reaction mixture was allowed to stir at rt for 4 h. 
The reaction mixture was diluted with water and extracted with Et2O (x 3). The combined organic extracts 
were dried (MgSO4), filtered and concentrated in vacuo. Chromatographic purification (eluent Et2O:petrol 
5:95) gave (E)-ethyl 3-phenylbut-2-enoate 69 as a colourless oil (2.35 g, 30%); δH (500 MHz, CDCl3) 1.35 
(3H, t, J 7.1, CH2CH3), 2.61 (3H, d, J 1.3, CH3), 4.25 (2H, q, J 7.1, CH2CH3), 6.16 (1H, q, J 1.2, =CH), 
7.38-7.42 (3H, m, ArH), 7.50-7.52 (2H, m, ArH). Data are in accordance with the literature.
45
 
(E)-3-phenylbut-2-enoic acid 70 
Following a literature procedure,
41
 a solution of (E)-ethyl 3-phenylbut-2-enoate 69 (2.35 g, 12.4 mmol) in 
0.5 M KOH (37.1 mL, 18.6 mmol) was heated at reflux for 16 h. Once cooled to rt the reaction mixture 
was extracted with Et2O (x 3). The reaction mixture was treated with 1M H2SO4 until acidic and extracted 
with Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered and concentrated in vacuo. 
Recrystallisation from Et2O gave (E)-3-phenylbut-2-enoic acid 70 as a white solid (1.39 g, 70%); mp 94-
 19 
96 °C; {lit.
46
 mp 95-97 °C}; δH (500 MHz, CDCl3) 2.64 (3H, d, J 1.2, CH3), 6.21 (1H, q, J 1.2, =CH), 
7.41-7.44 (3H, m, ArH), 7.51-7.54 (2H, m, ArH). Data are in accordance with the literature.
47 
(E)-ethyl 3,4-diphenylbut-2-enoate 71 
Following a literature procedure,
45 
to a suspension of 60% NaH in mineral oil (2.04 g, 51.0 mmol) in THF 
(50 mL) at 0 °C was added ethyl 2-(diethoxyphosphoryl)acetate (10.1 mL, 51.0 mmol) dropwise over 30 
minutes and the reaction mixture was stirred for 30 minutes at rt. A solution of 1,2-diphenylethanone (10 
g, 51.0 mmol) in THF (20 mL) was added dropwise and the reaction mixture was allowed to stir at rt for 4 
h. The reaction mixture was diluted with water and extracted with Et2O (x 3). The combined organic 
extracts were dried (MgSO4), filtered and concentrated in vacuo. Chromatographic purification (eluent 
Et2O:petrol 5:95) gave (E)-ethyl 3,4-diphenylbut-2-enoate 71 as a colourless oil (2.35 g, 17%); δH (300 
MHz, CDCl3) 1.35 (3H, t, J 7.1, CH2CH3), 4.27 (2H, q, J 7.1, CH2CH3), 4.55 (2H, s, CH2Ph), 6.29 (1H, d, 
=CH), 7.14-7.27 (5H, m, ArH), 7.33-7.36 (3H, m, ArH), 7.42-7.48 (2H, m, ArH). Data are in accordance 
with the literature.
48 
(E)-3,4-diphenylbut-2-enoic acid 72 
Following a literature procedure,
41
 a solution of (E)-ethyl 3,4-diphenylbut-2-enoate 71 (2.35 g, 8.84 
mmol) in 0.5 M KOH (26.8 mL, 13.3 mmol) was heated at reflux for 16 h. Once cooled to rt the reaction 
mixture was extracted with Et2O (x 3). The reaction mixture was treated with 1M H2SO4 until acidic and 
extracted with Et2O (x 3). The combined organic extracts were dried (MgSO4), filtered and concentrated 
in vacuo. Chromatographic purification (eluent Et2O:petrol 25:75) gave (E)-3,4-diphenylbut-2-enoic acid 
72 as a white solid (210 mg, 10%); mp 122-124 °C; {lit.
49
 mp 138-139 °C}; δH (300 MHz, CDCl3) 4.59 
(2H, s, CH2Ph), 6.34 (1H, s, =CH), 7.18-7.29 (5H, m, ArH), 7.34-7.39 (3H, m, ArH), 7.46-7.49 (2H, m, 
ArH). Data are in accordance with the literature.
49
 
General procedure A: Isothiourea catalysed intermolecular reactions. 
 20 
To a solution of acid (1-2 equiv.) in CH2Cl2 (~1 mL per 0.2 mmol of acid) were added iPr2NEt (1.5 equiv. 
based upon acid) and activating agent (1.5 equiv. based upon acid) at rt. The reaction mixture was allowed 
to stir at rt for 10 minutes. The requisite isothiourea (1-10 mol%), Michael acceptor/ketone/imine (1 
equiv.) and iPr2NEt (2.5 equiv.) were then added at the required temperature. The reaction mixture was 
stirred at the required temperature until complete by TLC. The reaction mixture was subsequently 
quenched by addition of HCl (1 M in H2O). The reaction mixture was poured into H2O and extracted with 
CH2Cl2 (x 3). The combined organics were dried (MgSO4), filtered and concentrated in vacuo to give the 
crude reaction mixture. 
(3S,4S)-4-phenyl-3-[(E)-2-phenylethynyl]-4-(trifluoromethyl)oxetan-2-one 21 and (3S,4R)-4-phenyl-
3-[(E)-2-phenylethynyl]-4-(trifluoromethyl)oxetan-2-one 73 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (259 mg, 1.60 mmol), iPr2NEt (0.42 mL, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), DHPB 17 (15.2 mg, 0.08 
mmol, 10 mol%), 2,2,2-trifluoro-1-phenylethan-1-one 18 (109 L, 0.80 mmol) and iPr2NEt (0.35 ml, 2.00 
mmol) for 1.5 h at rt gave crude lactones 21 and 73 (60:40 dr). Chromatographic purification (eluent 
Et2O:petrol 2.5:97.5) gave lactone 21 (>98:2 dr) as a white solid (110 mg, 43%) and lactone 73 (>98:2 dr) 
as a white solid (73.4 mg, 29%). 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (259 mg, 1.60 mmol), iPr2NEt (0.42 mL, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 
mg, 0.08 mmol, 10 mol%), 2,2,2-trifluoro-1-phenylethan-1-one 18 (109 L, 0.80 mmol) and iPr2NEt (0.35 
ml, 2.00 mmol) for 1.5 h at −78 °C gave crude lactones (3S,4S)-21 and (3R,4R)-73 (65:35 dr). 
Chromatographic purification (eluent Et2O:petrol 2.5:97.5) gave lactone (3S,4S)-21 (>98:2 dr) as a white 
solid (98.3 mg, 39%) and lactone (3R,4R)-73 (>98:2 dr) as a white solid (52.6 mg, 21 %):  
Data for lactone (3S,4S)-21: mp 66-67 °C; 

 
D
20
-14.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralcel OD-H 
(0.5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4R): 9.6 min, tR(3S,4S): 12.6 min, 79% ee; 
 21 
max (ATR)/cm
-1
 3080, 3030 (C-H), 1847 (C=O), 1698; δH (400 MHz, CDCl3) 4.95-4.98 (1H, m, C(3)H), 
5.64 (1H, dd, J 15.7, 9.4, PhCH=CH), 6.71 (1H, d, J 15.7, PhCH=CH), 7.20-7.23 (2H, m, ArH), 7.27-7.31 
(3H, m, ArH), 7.46-7.49 (5H, m, ArH); δC (100 MHz, CDCl3) 60.9 (C(3)), 79.5 (q, J 32.8, C(4)), 116.1 
(PhCH=CH), 123.6 (q, J 280, CF3), 126.9 (ArC), 127.3 (ArC), 128.8 (ArC), 128.8 (ArC), 128.9 (4ry ArC), 
129.0 (ArC), 130.1 (ArC), 135.3 (C(4)ArC(1), 138.4 (PhCH=CH), 165.9 (C(2)=O); F (376 MHz, CDCl3) 
-78.7 (CF3); m/z (APCI
+
) 319 ([M+H]
+
, 100%); HRMS (APCI
+
) C18H14F3O2
+
 ([M+H]
+
) requires 
319.0940; found 319.0940 (-0.1 ppm). 
Data for lactone (3S,4R)-73: mp 110-112 °C; 

 
D
20-93.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralcel OD-H 
(2% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3R,4S): 13.1 min, tR(3S,4R): 14.9 min, 77% ee; 
max (ATR)/cm
-1
 3080, 2944 (C-H), 1834 (C=O), 1692; δH (400 MHz, CDCl3) 4.77 (1H, d, J 8.7, C(3)H), 
6.38-6.47 (1H, m, PhCH=CH), 6.83-6.88 (1H, m, PhCH=CH), 7.34-7.50 (9H, m, ArH); δC (100 MHz, 
CDCl3) 64.9 (C(3)), 79.6 (q, J 30.1, C(4)), 115.1 (PhCH=CH), 123.3 (q, J 281, CF3), 126.3 (ArC), 127.1 
(ArC), 128.9 (ArC), 128.9 (ArC), 129.1 (ArC), 130.2 (ArC), 132.9 (4ry ArC), 135.4 (C(4)ArC(1)), 139.0 
(PhCH=CH), 165.9 (C(2)=O); F (376 MHz, CDCl3) -74.2 (CF3); m/z (APCI
+
) 319 ([M+H]
+
, 100%); 
HRMS (APCI
+
) C18H14F3O2
+
 ([M+H]
+
) requires 319.0940; found 319.0941 (+0.2 ppm). 
(3S,4R)-1-[(4-methylbenzene)sulfonyl]-4-phenyl-3-[(E)-2-phenylethenyl]azetidin-2-one 22 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (259 mg, 1.60 mmol), iPr2NEt (0.42 mL, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), DHPB 17 (15.2 mg, 0.08 
mmol, 10 mol%), imine 19 (207 mg, 0.80 mmol) (109 L, 0.80 mmol) and iPr2NEt (0.35 ml, 2.00 mmol) 
for 1.5 h at rt gave crude lactam 22 (83:17 dr). Chromatographic purification (eluent Et2O:petrol 20:80) 
gave lactam 22 (>98:2 dr) as a white solid (219 mg, 68%). 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (260 mg, 1.60 mmol), iPr2NEt (420 L, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 
mg, 0.08 mmol, 10 mol%), imine 19 (207 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
 22 
gave crude lactam (3S,4R)-22 (85:15 dr). Chromatographic purification (eluent Et2O:petrol 20:80) gave 
lactam (3S,4R)-22 (>98:2 dr) as a white solid (125 mg, 39%); mp 137-139 °C; 

 
D
20+9.8 (c 0.5, CH2Cl2); 
Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4R): 24.4 
min, tR(3R,4S): 40.9 min, 72% ee; max (ATR)/cm
-1
 3024, 2924 (C-H), 1790 (C=O), 1450, 1359 (S=O), 
1165 (S=O); Data for major diastereoisomer: δH (300 MHz, CDCl3) 2.44 (3H, s, CH3), 3.91 (1H, ddd, J 
8.0, 3.3, 1.1 Hz, C(3)H), 4.90 (1H, d, J 3.3 Hz, C(4)H), 6.16 (1H, dd, J 15.9, 8.0 Hz, PhCH=CH), 6.53 
(1H, dd, J 15.9, 1.1 Hz, PhCH=CH), 7.24-7.36 (12H, m, ArH), 7.65-7.69 (2H, m, SO2Ar(2,6)H); δC (100 
MHz, CDCl3) 21.8 (CH3), 62.9 (C(3)), 64.3 (C(4)), 119.3 (HC=CHPh), 126.6 (ArC), 126.8 (ArC), 127.7 
(ArC), 128.4 (ArC), 128.8 (ArC), 129.1 (ArC), 129.1 (ArC), 130.0 (ArC), 135.8 (HC=CHPh), 135.8 (4ry 
ArC), 135.8 (4ry ArC), 135.8 (4ry ArC), 145.4 (C(4)ArC(1)), 165.2 (C(2)=O); m/z (NSI) 404 ([M+H]
+
, 
65%); HRMS (NSI) C24H22NO3S
+
 ([M+H]
+
) requires 404.1315; found 404.1313 (-0.5 ppm). 
(3S,4S)-1-[(4-methylbenzene)sulfonyl]-4-phenyl-3-[(E)-2-phenylethenyl]azetidin-2-one 74 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (260 mg, 1.60 mmol), iPr2NEt (420 L, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 
mg, 0.08 mmol, 10 mol%), imine 19 (207 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 2.5 h at 
−78 °C gave crude lactam (3S,4S)-74 (83:17 dr). Chromatographic purification (eluent Et2O:petrol 20:80) 
gave lactam (3S,4S)-74 (>98:2 dr) as a white solid (136 mg, 42%); mp 127-129 °C; 

 
D
20
-6.4 (c 0.5, 
CH2Cl2); Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
tR(3S,4S): 23.0 min, tR(3R,4R): 46.8 min, 16% ee; max (ATR)/cm
-1
 3024, 2924 (C-H), 1790 (C=O), 1450, 
1359 (S=O), 1165 (S=O); Data for major diastereoisomer: δH (500 MHz, CDCl3) 2.48 (3H, s, CH3), 4.40-
4.42 (1H, m, C(3)H), 5.38 (1H, d, J 6.7 Hz, C(4)H), 5.49 (1H, dd, J 15.9, 7.3 Hz, PhCH=CH), 6.61 (1H, d, 
J 15.8 Hz, PhCH=CH), 7.06-7.07 (2H, m, ArH), 7.16-7.24 (5H, m, ArH), 7.28-7.34 (5H, m, Ar-H), 7.80 
(2H, d, J 8.4 Hz, SO2Ar(2,6)H); δC (100 MHz, CDCl3) 21.9 (CH3), 58.1 (C(4)), 61.8 (C(3)), 118.4 
(HC=CHPh), 126.5 (C(4)ArC(2,6)), 127.5 (ArC), 127.8 (ArC), 128.2 (ArC), 128.6 (ArC), 128.6 (ArC), 
 23 
128.9 (ArC), 130.0 (ArC), 133.7 (4ry ArC), 135.8 (4ry ArC), 135.9 (HC=CHPh), 136.1 (4ry ArC), 145.5 
(C(4)ArC(1)), 165.0 (C(2)=O); m/z (NSI) 404 ([M+H]
+
, 70%); HRMS (NSI) C24H22NO3S
+
 ([M+H]
+
) 
requires 404.1314; found 404.1313 (-0.2 ppm). 
(3S,4R)-4-(4-bromophenyl)-1-[(4-methylbenzene)sulfonyl]-3-[(1E)-prop-1-en-1-yl]azetidin-2-one 26 
and (3S,4S)-4-(4-bromophenyl)-1-[(4-methylbenzene)sulfonyl]-3-[(1E)-prop-1-en-1-yl]azetidin-2-one 
27 
Following general procedure A, (E)-pent-3-enoic acid 24 (162 L, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 25  (270 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactams (3S,4R)-26 and (3S,4S)-27 (68:32 dr). Chromatographic purification (eluent 
Et2O:petrol 20:80) gave lactam (3S,4R)-26 (>98:2 dr) as a colourless oil (177 mg, 53%) and lactam 
(3S,4S)-27 (>98:2 dr) as a white solid (91 mg, 27%):  
Data for lactam (3S,4R)-26: Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 220 
nm, 30 °C) tR(3S,4R): 18.6 min, tR(3R,4S): 47.0 min, 79% ee; max (ATR)/cm
-1
 3032, 2965 (C-H), 1794 
(C=O), 1595, 1366 (S=O), 1169 (S=O); δH (400 MHz, CDCl3) 1.68 (3H, ddd, J 6.5, 1.6, 0.8 Hz, 
CH3CH=CH), 2.44 (3H, s, ArCH3), 3.64 (1H, ddt, J 8.0, 3.3, 0.9 Hz, C(3)H), 4.70 (1H, d, J 3.3 Hz, 
C(4)H), 5.38-5.45 (1H, m, CH3CH=CH), 5.62-5.69 (1H, m, CH3CH=CH), 7.07-7.11 (2H, m, ArH), 7.26-
7.29 (2H, m, SO2Ar(3,5)H), 7.40-7.43 (2H, m, ArH), 7.64-7.67 (2H, m, SO2Ar(2,6)H); δC (125 MHz, 
CDCl3) 18.2 (CH3CH=CH), 21.8 (ArCH3), 62.8 (C(3)), 63.4 (C(4)), 121.0 (CH3CH=CH), 123.0 
(C(4)ArC(4)), 127.6 (ArC), 128.2 (ArC), 130.0 (ArC), 132.1 (ArC), 133.1 (CH3CH=CH)), 135.1 (4ry 
ArC), 135.5 (4ry ArC), 145.5 (C(4)ArC(1)), 165.4 (C(2)=O); m/z (APCI) 420 ([M+H]
+
, 98%); HRMS 
(APCI) C19H18BrNO3S
+
 ([M+H]
+
) requires 420.0264; found 420.0266 (+0.6 ppm). 
Data for lactam (3S,4S)-27: mp 92-94 °C; Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 30 °C) tR(3S,4S): 20.9 min, tR(3R,4R): 23.0 min, 72% ee; max (ATR)/cm
-1
 2941, 2926, 
 24 
(C-H), 1786 (C=O), 1487, 1368 (S=O), 1125 (S=O); δH (400 MHz, CDCl3) 1.51 (3H, ddd, J 6.6, 1.7, 1.0 
Hz, CH3CH=CH), 2.46 (3H, s, ArCH3), 4.16 (1H, ddt, J 7.8, 6.7, 1.1, C(3)H), 4.78 (1H, ddq, J 15.3, 7.7, 
1.7 Hz, CH3CH=CH), 5.17 (1H, d, J 6.7 Hz, C(4)H), 5.69 (1H, dqd, J 15.3, 6.6, 1.3 Hz, CH3CH=CH), 
6.97-7.00 (2H, m, ArH), 7.31-7.33 (2H, m, SO2Ar(3,5)H), 7.40-7.42 (2H, m, ArH), 7.75-7.77 (2H, m, 
SO2Ar(2,6)H); δC (125 MHz, CDCl3) 18.2 (CH3CH=CH), 21.9 (ArCH3), 58.3 (C(3)), 61.1 (C(4)), 119.4 
(CH3CH=CH), 122.7 (C(4)ArC(4)), 127.7 (ArC), 129.1 (ArC), 130.1 (ArC), 131.7 (ArC), 133.2 (4ry ArC), 
133.9 (CH3CH=CH)), 135.6 (4ry ArC), 145.7 (C(4)ArC(1)), 165.4 (C(2)=O); m/z (NSI) 420 ([M+H]
+
, 
100%); HRMS (NSI) C19H18BrNO3S
+
 ([M+H]
+
) requires 420.0264; found 420.0263 (-0.1 ppm). 
Reaction carried out for 1.5 h at −78 °C gave crude lactams (3S,4R)-26:(3S,4S)-27 (71:29 dr). 
Chromatographic purification (eluent Et2O:petrol 20:80) gave lactam (3S,4R)-26 (>98:2 dr) as a colourless 
oil (179 mg, 53%) with identical spectroscopic properties as before in 97% ee; 

 
D
20
0.6 (c 0.5, CH2Cl2) 
and lactam (3S,4S)-27 (>98:2 dr) as a white solid (35.6 mg, 11%) with identical spectroscopic properties 
as before in >99% ee; 

 
D
20
-14.6 (c 0.5, CH2Cl2). 
(3S,4R)-4-(4-methoxyphenyl)-1-[(4-methylbenzene)sulfonyl]-3-[(1E)-prop-1-en-1-yl]azetidin-2-one 
28 
Following general procedure A, (E)-pent-3-enoic acid 24 (162 L, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 53  (231 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactam (3S,4R)-28 (80:20 dr). Chromatographic purification (eluent Et2O:petrol 30:70) gave 
lactam (3S,4R)-28 (96:4 dr) as a yellow oil (220 mg, 74%); 

 
D
20
-11.2 (c 0.5, CH2Cl2); Chiral HPLC 
Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4R): 17.6 min, tR(3R,4S): 
53.0 min, 86% ee; max (ATR)/cm
-1
 2966 (C-H), 1790 (C=O), 1612, 1516, 1364 (S=O), 1167 (S=O); Data 
for major diastereomer: δH (500 MHz, CDCl3) 1.68 (3H, ddd, J 6.5, 1.6, 0.8 Hz, CH3CH=CH), 2.42 (3H, s, 
ArCH3), 3.67 (1H, ddt, J 8.0, 3.3, 0.9 Hz, C(3)H), 3.80 (3H, s, OCH3), 4.73 (1H, d, J 3.3 Hz, C(4)H), 5.43 
 25 
(1H, ddq, J 15.3, 8.0, 1.6 Hz, CH3CH=CH), 5.63-5.70 (1H, m, CH3CH=CH), 6.80-6.81 (2H, m, 
C(4)Ar(3,5)H), 7.12-7.14 (2H, m, C(4)Ar(2,6)H), 7.24 (2H, d, J 8.6 Hz, SO2Ar(3,5)H), 7.60-7.61 (2H, m, 
SO2Ar(2,6)H); δC (125 MHz, CDCl3) 18.2 (CH3CH=CH), 21.8 (ArCH3), 55.5 (OCH3), 62.6 (C(3)), 64.0 
(C(4)), 114.3 (C(4)ArC(3,5)), 121.4 (CH3CH=CH), 127.6 (SO2ArC(2,6)), 127.8 (C(4)ArC(1)), 128.2 
(C(4)ArC(2,6)), 129.8 (SO2ArC(3,5)), 132.6 (CH3CH=CH)), 135.9 (SO2ArC(1)), 145.1 (SO2ArC(4)), 
160.2 (C(4)ArC(4)), 165.9 (C(2)=O); m/z (ESI) 394 ([M+Na]
+
, 80%); HRMS (ESI) C20H21NNaO4S
+
 
([M+Na]
+
) requires 394.1089; found 394.1075 (-2.2 ppm). 
(3S,4R)-1-[(4-methylbenzene)sulfonyl]-3-[(1E)-prop-1-en-1-yl]-4-[4-
(trifluoromethyl)phenyl]azetidin-2-one 29 
Following general procedure A, (E)-pent-3-enoic acid 24 (162 L, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 54  (262 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactam (3S,4R)-29 (87:13 dr). Chromatographic purification (eluent Et2O:petrol 20:80) gave 
lactam (3S,4R)-29 (>98:2 dr) as a colourless oil (151 mg, 46%); 

 
D
20
+1.0 (c 0.5, CH2Cl2); Chiral HPLC 
Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4R): 20.3 min, tR(3R,4S): 
48.4 min, 44% ee; max (ATR)/cm
-1
 2970 (C-H), 1796 (C=O), 1597, 1323 (S=O), 1165 (S=O); Data for 
major diastereomer: δH (400 MHz, CDCl3) 1.69 (3H, ddd, J 6.5, 1.6, 0.8 Hz, CH3CH=CH), 2.44 (3H, s, 
ArCH3), 3.67 (1H, ddt, J 8.0, 3.3, 0.9 Hz, C(3)H), 4.79 (1H, d, J 3.3 Hz, C(4)H), 5.39-5.46 (1H, m, 
CH3CH=CH), 5.64-5.73 (1H, m, CH3CH=CH), 7.25-7.28 (2H, m, SO2Ar(3,5)H), 7.35 (2H, d, J 8.3 Hz, 
C(4)Ar(3,5)H), 7.55 (2H, d, J 8.1 Hz, C(4)Ar(2,6)H), 7.65-7.68 (2H, m, SO2Ar(2,6)H); δC (125 MHz, 
CDCl3) 18.2 (CH3CH=CH), 21.8 (ArCH3), 63.0 (C(3) or C(4)), 63.2 (C(3) or C(4)), 120.8 (CH3CH=CH), 
123.9 (q, J 271 Hz, CF3), 125.9 (q, J 3.5 Hz, C(4)ArC(3,5)), 126.9 (C(4)ArC(2,6)), 127.6 (SO2ArC(2,6)), 
130.0 (SO2ArC(3,5)), 131.2 (q, J 32.5 Hz, C(4)ArC(4)), 133.4 (CH3CH=CH), 135.4 (SO2ArC(1)), 140.2 
(C(4)ArC(1)), 145.7 (SO2ArC(4)), 165.2 (C(2)=O); δF (376 MHz, CDCl3) -63.3 (CF3); m/z (NSI) 410 
([M+H]
+
, 15%); HRMS (NSI) C20H19F3NO3S
+
 ([M+H]
+
) requires 410.1032; found 410.1030 (-0.5 ppm) 
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 (3S,3R)-4-(furan-2-yl)-1-[(4-methylbenzene)sulfonyl]-3-[(1E)-prop-1-en-1-yl]azetidin-2-one 30 
Following general procedure A, (E)-pent-3-enoic acid 24 (162 L, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 55 (199 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactam (3S,4R)-30 (73:27 dr). Chromatographic purification (eluent Et2O:petrol 20:80) gave 
lactam (3S,4R)-30 (95:5 dr) as a white solid (171 mg, 65%); mp 137-139 °C; Chiral HPLC Chiralpak AD-
H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(3S,4R): 11.6 min, tR(3R,4S): 13.4 min, 45% 
ee; max (ATR)/cm
-1
 2976 (C-H), 1788 (C=O), 1595, 1362 (S=O), 1165 (S=O); Data for major 
diastereoisomer: δH (400 MHz, CDCl3) 1.71 (3H, ddd, J 6.5, 1.6, 0.9 Hz, CH3CH=CH), 2.42 (3H, s, 
ArCH3), 4.00-4.03 (1H, m, C(3)H), 4.86-4.87 (1H, m, C(4)H), 5.45-5.52 (1H, m, CH3CH=CH), 5.71-5.80 
(1H, m, CH3CH=CH), 6.35 (1H, dd, J 3.3, 1.9 Hz, C(4)ArC(4)H), 6.50 (1H, dd, J 3.3, 0.7 Hz, 
C(4)ArC(3)H), 7.20  (1H, dt, J 1.0, 0.5 Hz, C(4)ArC(5)H), 7.22-7.24 (2H, m, SO2Ar(3,5)H), 7.52-7.55 
(2H, m, SO2Ar(2,6)H); δC (125 MHz, CDCl3) 18.2 (CH3CH=CH), 21.8 (ArCH3), 56.7 (C(3)), 58.7 (C(4)), 
110.9 (C(4)ArC), 112.0 (C(4)ArC), 121.1 (CH3CH=CH), 127.4 (SO2ArC(2,6)), 129.8 (SO2ArC(3,5)), 
133.0 (CH3CH=CH)), 135.7 (C(4)ArC(1)), 143.5 (C(4)ArC(5)), 145.0 (SO2ArC(1)), 147.6 (SO2ArC(4)), 
164.9 (C(2)=O); m/z (APCI) 332 ([M+H]
+
, 100%); HRMS (APCI) C17H18NO4S
+
 ([M+H]
+
) requires 
332.0951; found 332.0954 (+0.9 ppm).  
Reaction carried out for 1.5 h at −78 °C gave crude lactam (3S,4R)-30 (63:37 dr). Chromatographic 
purification (eluent Et2O:petrol 20:80) gave lactam (3S,4R)-30 (95:5 dr) as a white solid (126 mg, 48%) 
with identical spectroscopic properties as before in 95% ee; 

 
D
20
-6.4 (c 0.5, CH2Cl2). 
(3S,4R)-1-[(4-methylbenzene)sulfonyl]-4-(naphthalen-2-yl)-3-[(1E)-prop-1-en-1-yl]azetidin-2-one 31 
and (3S,4S)-1-[(4-methylbenzene)sulfonyl]-4-(naphthalen-2-yl)-3-[(1E)-prop-1-en-1-yl]azetidin-2-
one 75 
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Following general procedure A, (E)-pent-3-enoic acid 24 (162 L, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 56  (247 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactams (3S,4R)-31 and (3S,4S)-75 (67:33 dr). Chromatographic purification (eluent 
Et2O:petrol 20:80) gave lactam (3S,4R)-31 (>98:2 dr) as a colourless oil (188 mg, 60%) and lactam 
(3S,4S)-75 (94:6 dr) as a colourless oil (96 mg, 31%):  
Data for lactam (3S,4R)-31: Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) tR(3S,4R): 17.1 min, tR(3R,4S): 37.0 min, 81% ee; max (ATR)/cm
-1
 2972 (C-H), 1792 (C=O), 
1699, 1364 (S=O), 1167 (S=O); δH (500 MHz, CDCl3) 1.71 (3H, ddd, J 6.5, 1.5, 0.7 Hz, CH3CH=CH), 
2.38 (3H, s, ArCH3), 3.77 (1H, ddd, J 7.9, 2.4, 0.8 Hz, C(3)H), 4.95 (1H, d, J 3.3 Hz, C(4)H), 5.48-5.53 
(1H, m, CH3CH=CH), 5.68-5.72 (1H, m, CH3CH=CH), 7.14-7.16 (2H, m, SO2Ar(3,5)H), 7.23 (1H, dd, J 
8.5, 1.8 Hz, C(4)ArH), 7.49-7.53 (2H, m, ArH), 7.60-7.63 (2H, m, SO2Ar(2,6)H), 7.70-7.72 (1H, m, 
C(4)Ar(1)H), 7.74 (1H, d, J 8.5, C(4)ArH), 7.81-7.84 (1H, m, C(4)ArH); δC (125 MHz, CDCl3) 18.2 
(CH3CH=CH), 21.7 (ArCH3), 62.9 (C(3)), 64.4 (C(4)), 121.3 (CH3CH=CH), 123.3 (ArC), 126.6 (ArC), 
126.7 (ArC), 126.8 (ArC), 127.6 (SO2ArC(2,6)), 127.8 (ArC), 128.1 (ArC), 129.0 (ArC), 129.8 
(SO2ArC(3.5)), 132.9 (CH3CH=CH)), 133.0 (4ry ArC), 133.1 (4ry ArC), 133.5 (4ry ArC), 135.7 (4ry ArC), 
145.4 (C(4)ArC(1)), 165.7 (C(2)=O); m/z (APCI) 392 ([M+H]
+
, 26%); HRMS (APCI) C23H22NO3S
+
 
([M+H]
+
) requires 392.1315; found 392.1318 (+0.8 ppm). 
Data for lactam (3S,4S)-75: Chiral HPLC Chiralcel OD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) tR(3S,4S): 19.2 min, tR(3R,4R): 25.0 min, 81% ee; max (ATR)/cm
-1
 2972 (C-H), 1790 (C=O), 
1597, 1364 (S=O), 1169 (S=O); δH (400 MHz, CDCl3) 1.43 (3H, ddd, J 6.6, 1.7, 1.0 Hz, CH3CH=CH), 
2.43 (3H, s, ArCH3), 4.26 (1H, ddq, J 7.8, 6.8, 1.0, C(3)H), 4.84 (1H, ddq, J 15.3, 7.8, 1.7 Hz, 
CH3CH=CH), 5.42 (1H, d, J 6.7 Hz, C(4)H), 5.66-5.75 (1H, m, CH3CH=CH), 7.13 (1H, dd, J 8.5, 1.9 Hz, 
C(4)ArH), 7.24-7.27 (2H, m, SO2Ar(3,5)H), 7.48-7.52 (2H, m, ArH), 7.55 (1H, dd, J 1.2, 0.5, 
C(4)Ar(1)H), 7.66-7.68 (1H, m, C(4)ArH), 7.72-7.77 (3H, m, ArH), 7.81-7.84 (1H, m, C(4)ArH); δC (100 
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MHz, CDCl3) 18.1 (CH3CH=CH), 21.8 (ArCH3), 58.6 (C(3)), 62.0 (C(4)), 119.7 (CH3CH=CH), 124.8 
(ArC), 126.6 (ArC), 126.6 (ArC), 127.1 (ArC), 127.8 (ArC), 127.8 (SO2ArC(2,6)), 128.1 (ArC), 128.3 
(ArC), 130.0 (SO2ArC(3,5)), 131.5 (4ry ArC), 133.0 (4ry ArC), 133.4 (4ry ArC), 133.6 (CH3CH=CH), 
135.9 (4ry ArC), 145.4 (C(4)ArC(1)), 165.7 (C(2)=O); m/z (APCI) 392 ([M+H]
+
, 83%); HRMS (APCI) 
C23H22NO3S
+
 ([M+H]
+
) requires 392.1315; found 392.1316 (+0.3 ppm). 
Reaction carried out for 1.5 h at −78 °C gave crude lactams (3S,4R)-31:(3S,4S)-75 (76:24 dr). 
Chromatographic purification (eluent Et2O:petrol 20:80) gave lactam (3S,4R)-31 (>98:2 dr) as a colourless 
oil (201 mg, 64%) with identical spectroscopic properties as before in 97% ee; 

 
D
20-10.6 (c 0.5, CH2Cl2) 
and lactam (3S,4S)-75 (95:5 dr) as a colourless oil (69.0 mg, 22%) with identical spectroscopic properties 
as before in 99% ee; 

 
D
20
+0.6 (c 0.5, CH2Cl2). 
(3S,4R)-3-[(1E)-but-1-en-1-yl]-1-[(4-methylbenzene)sulfonyl]-4-phenylazetidin-2-one 32 and (3S,4S)-
3-[(1E)-but-1-en-1-yl]-1-[(4-methylbenzene)sulfonyl]-4-phenylazetidin-2-one 76 
Following general procedure A, (E)-hex-3-enoic acid 81 (190 L, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 19  (207 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactams (3S,4R)-32 and (3S,4S)-76 (84:16 dr). Chromatographic purification (eluent 
Et2O:petrol 20:80) gave lactam (3S,4R)-32 (>98:2 dr) as a colourless oil (158 mg, 55%) and lactam 
(3S,4S)-76 (98:2 dr) as a white solid (22 mg, 8%):  
Data for lactam (3S,4R)-32: Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) tR(3S,4R): 11.5 min, tR(3R,4S): 17.8 min, 81% ee; max (ATR)/cm
-1
 2967 (C-H), 1794 (C=O), 
1699, 1366 (S=O), 1169 (S=O); Data for major diastereomer: δH (500 MHz, CDCl3) 0.95 (3H, t, J 7.5 Hz, 
CH2CH3), 2.00-2.07 (2H, m, CH2CH3), 2.42 (3H, s, ArCH3), 3.70 (1H, ddt, J 7.8, 2.4, 0.9 Hz, C(3)H), 
4.77 (1H, d, J 3.3 Hz, C(4)H), 5.42 (1H, ddt, J 15.4, 7.8, 1.6 Hz, EtCH=CH), 5.70 (1H, dtd, J 15.4, 6.3, 
1.1 Hz, EtCH=CH), 7.21-7.25 (4H, m, ArH), 7.27-7.34 (3H, m, ArH), 7.62-7.64 (2H, m, SO2Ar(2,6)H); 
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δC (125 MHz, CDCl3) 13.1 (CH2CH3), 21.8 (ArCH3), 25.6 (CH2CH3), 62.6 (C(3) or C(4)), 64.2 (C(3) or 
C(4)), 119.1 (EtCH=CH), 126.7 (C(4)ArC(2,6)), 127.6 (SO2ArC(2,6)), 128.9 (C(4)ArC(3,5)), 129.0 
(C(4)ArC(4)), 129.9 (SO2ArC(3.5)), 135.7 (4ry ArC), 136.0 (4ry ArC), 139.3 (EtCH=CH)), 145.2 
(C(4)ArC(1)), 165.8 (C(2)=O); m/z (NSI) 356 ([M+H]
+
, 37%); HRMS (NSI) C20H22NO3S
+
 ([M+H]
+
) 
requires 356.1315; found 356.1316 (+0.3 ppm). 
Data for lactam (3S,4S)-76: mp 85-87 °C; Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 
mL min
-1
, 211 nm, 30 °C) tR(3S,4S): 14.9 min, tR(3R,4R): 27.9 min, 74% ee; max (ATR)/cm
-1
 2967 (C-H), 
1788 (C=O), 1456, 1368 (S=O), 1171 (S=O); Data for major diastereomer: δH (500 MHz, CDCl3) 0.72 
(3H, t, J 7.4 Hz, CH3CH2), 1.78-1.84 (2H, m, CH3CH2), 2.45 (3H, s, ArCH3), 4.16 (1H, ddd, J 7.6, 6.7, 
1.0, C(3)H), 4.76 (1H, ddt, J 15.5, 7.6, 1.6 Hz, EtCH=CH), 5.24 (1H, d, J 6.7 Hz, C(4)H), 5.69 (1H, dtd, J 
15.5, 6.4, 1.2 Hz, EtCH=CH), 7.08-7.11 (2H, m, ArH), 7.25-7.31 (5H, m, ArH), 7.76-7.78 (2H, m, 
SO2Ar(2,6)H); δC (100 MHz, CDCl3) 13.1 (CH3CH2), 21.8 (ArCH3), 25.6 (CH3CH2), 58.2 (C(3), 61.8 
(C(4)), 117.7 (EtCH=CH), 127.5 (C(4)ArC(2,6)), 127.8 (SO2ArC(2,6)), 128.4 (C(4)ArC(3,5)), 128.6 
(C(4)ArC(4)), 130.0 (SO2ArC(3.5)), 134.0 (4ry ArC), 135.8 (4ry ArC), 140.0 (EtCH=CH)), 145.4 
(C(4)ArC(1)), 165.7 (C(2)=O); m/z (NSI) 356 ([M+H]
+
, 39%); HRMS (NSI) C20H22NO3S
+
 ([M+H]
+
) 
requires 356.1315; found 356.1316 (+0.3 ppm) 
Reaction carried out for 1.5 h at −78 °C gave crude lactams (3S,4R)-32:(3S,4S)-76 (82:18 dr). 
Chromatographic purification (eluent Et2O:petrol 20:80) gave lactam (3S,4R)-32 (>98:2 dr) as a colourless 
oil (189 mg, 67%) with identical spectroscopic properties as before in 98% ee; 

 
D
20
+2.4 (c 0.5, CH2Cl2) 
and lactam (3S,4S)-76 (98:2 dr) as a white solid (47.0 mg, 16%) with identical spectroscopic properties as 
before in >99% ee; 

 
D
20
-9.3 (c 0.5, CH2Cl2). 
(3S,4R)-1-[(4-methylbenzene)sulfonyl]-3-[(1E)-3-methylbut-1-en-1-yl]-4-phenylazetidin-2-one 33 
Following general procedure A, (E)-5-methylhex-3-enoic acid 65 (205 mg, 1.60 mmol), iPr2NEt (420 L, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 
 30 
mg, 0.08 mmol, 10 mol%), imine 19 (207 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactam (3S,4R)-33 (73:27 dr). Chromatographic purification (eluent Et2O:petrol 15:85) gave 
lactam (3S,4R)-33 (>98:2 dr) as a colourless solid (155 mg, 53%); Chiral HPLC Chiralpak AD-H (10% 
IPA:hexane, flow rate 1 mL min
-1
, 220 nm, 30 °C) tR(3S,4R): 9.9 min, tR(3R,4S): 14.4 min, 82% ee; max 
(ATR)/cm
-1
 2961 (C-H), 1794 (C=O), 1597, 1435, 1366 (S=O), 1169 (S=O); Data for major diastereomer: 
δH (500 MHz, CDCl3) 0.95 (6H, d, J 6.8 Hz, CH(CH3)2), 2.23-2.30 (1H, m, CH(CH3)2), 2.42 (3H, s, 
ArCH3), 3.68-3.70 (1H, m, C(3)H), 4.77 (1H, d, J 3.3 Hz, C(4)H), 5.38 (1H, ddd, J 15.5, 7.7, 1.4 Hz, 
iPrCH=CH), 5.62 (1H, ddd, J 15.5, 6.5, 1.1 Hz, iPrCH=CH), 7.21-7.25 (4H, m, ArH), 7.27-7.34 (3H, m, 
ArH), 7.62-7.64 (2H, m, SO2Ar(2,6)H); δC (125 MHz, CDCl3) 21.8 (ArCH3), 22.0 (CH(CH3)2), 31.2 
(CH(CH3)2), 62.5 (C(3)), 64.3 (C(4)), 117.3 (iPrCH=CH), 126.7 (C(4)ArC(2,6)), 127.6 (SO2ArC(2,6)), 
128.9 (C(4)ArC(3,5)), 129.0 (C(4)ArC(4)), 129.8 (SO2ArC(3,5)), 135.7 (4ry ArC), 136.0 (4ry ArC), 144.4 
(iPrCH=CH), 145.2 (C(4)ArC(1)), 165.8 (C(2)=O); m/z (NSI) 370 ([M+H]
+
, 32%); HRMS (NSI) 
C21H24NO3S
+
 ([M+H]
+
) requires 370.1471; found 370.1472 (+0.2 ppm). 
Reaction carried out for 1.5 h at -78 °C gave crude lactam (3S,4R)-33 (79:21 dr). Chromatographic 
purification (eluent Et2O:petrol 15:85) gave lactam (3S,4R)-33 (>98:2 dr) as a colourless oil (185 mg, 
63%) with identical spectroscopic properties as before in 97% ee; 

 
D
20
+1.6 (c 0.5, CH2Cl2). 
(3S,4R)-1-[(4-methylbenzene)sulfonyl]-4-phenyl-3-[(1E)-3-phenylprop-1-en-1-yl]azetidin-2-one 34 
and (3S,4S)-1-[(4-methylbenzene)sulfonyl]-4-phenyl-3-[(1E)-3-phenylprop-1-en-1-yl]azetidin-2-one 
77  
Following general procedure A, (E)-5-phenylpent-3-enoic acid 66
 
(282 mg, 1.60 mmol), iPr2NEt (420 L, 
2.40 mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 
mg, 0.08 mmol, 10 mol%), imine 19 (207 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactams (3S,4R)-34 and (3S,4S)-77 (72:28 dr). Chromatographic purification (eluent 
 31 
Et2O:petrol 25:75) gave lactam (3S,4R)-34 (>98:2 dr) as a colourless oil (197 mg, 59%) and lactam 
(3S,4S)-77 (95:5 dr) as a colourless oil (61 mg, 18%): 
 
Data for lactam (3S,4R)-34: Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) tR(3S,4R): 18.4 min, tR(3R,4S): 25.3 min, 62% ee; max (ATR)/cm
-1
 3028 (C-H), 1792 (C=O), 
1597, 1364 (S=O), 1169 (S=O); Data for major diastereoisomer: δH (500 MHz, CDCl3) 2.42 (3H, s, 
ArCH3), 3.37 (2H, d. J 6.7 Hz, PhCH2), 3.76 (1H, ddd, J 7.7, 3.3, 0.9 Hz, C(3)H), 4.81 (1H, d, J 3.3 Hz, 
C(4)H), 5.51 (1H, ddt, J 15.4, 7.7, 1.5 Hz, BnCH=CH), 5.84 (1H, dtd, J 15.3, 6.7, 1.2 Hz, BnCH=CH), 
7.12-7.14 (2H, m, ArH), 7.20-7.23 (5H, m, ArH), 7.28-7.35 (5H, m, ArH), 7.62-7.64 (2H, m, SO2(2,6)H); 
δC (125 MHz, CDCl3) 21.8 (ArCH3), 38.9 (PhCH2CH=CH), 62.3 (C(3)), 64.1 (C(4)), 121.4 (BnCH=CH), 
126.4 (ArC), 126.7 (ArC), 127.5 (ArC), 128.6 (ArC), 128.6 (ArC), 128.9 (ArC), 129.1 (C(4)ArC(4)), 129.8 
(SO2ArC(3,5)), 135.7 (4ry ArC), 135.8 (4ry ArC), 136.1 (BnCH=CH), 139.0 (SO2ArC(1)), 145.2 
(C(4)ArC(1)), 165.4 (C(2)=O); m/z (NSI) 418 ([M+H]
+
, 20%); HRMS (NSI) C25H24NO3S
+
 ([M+H]
+
) 
requires 418.1471; found 418.1467 (-1.1 ppm). 
Data for lactam (3S,4S)-77: Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) tR(3S,4S): 14.4 min, tR(3R,4R): 26.7 min, 39% ee; max (ATR)/cm
-1
 3028, 2924 (C-H), 1788 
(C=O), 1595, 1359 (S=O), 1167 (S=O); Data for minor diastereoisomer: δH (500 MHz, CDCl3) 2.45 (3H, 
s, ArCH3), 3.12 (2H, d. J 6.7 Hz, PhCH2), 4.18-4.21 (1H, m, C(3)H), 4.85 (1H, ddt, J 15.4, 7.7, 1.5 Hz, 
BnCH=CH), 5.26 (1H, d, J 6.7 Hz, C(4)H), 5.78 (1H, dtd, J 15.4, 6.8, 1.2, BnCH=CH), 6.76-6.79 (2H, m, 
ArH), 7.08-7.23 (5H, m, ArH), 7.27-7.35 (5H, m, ArH), 7.77-7.79 (2H, m, SO2(2,6)H); δC (125 MHz, 
CDCl3) 21.9 (ArCH3), 38.9 (PhCH2), 58.1 (C(3)), 61.8 (C(4)), 120.4 (BnCH=CH), 126.2 (ArC), 127.4 
(ArC), 127.8 (ArC), 128.4 (ArC), 128.6 (ArC), 128.7 (ArC), 128.7 (ArC), 130.0 (SO2ArC(3,5)), 134.0 (4ry 
ArC), 135.7 (4ry ArC), 136.8 (BnCH=CH), 138.9 (SO2ArC(1)), 145.5 (C(4)ArC(1)), 165.4 (C(2)=O); m/z 
(NSI) 418 ([M+H]
+
, 28%); HRMS (NSI) C25H24NO3S
+
 ([M+H]
+
) requires 418.1471; found 418.1459 (-3.0 
ppm) 
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Reaction carried out for 1.5 h at −78 °C gave crude lactams (3S,4R)-34:(3S,4S)-77 (72:28 dr). 
Chromatographic purification (eluent Et2O:petrol 25:75) gave lactam (3S,4R)-34 (>98:2 dr) as a colourless 
oil (189 mg, 57%) with identical spectroscopic properties as before in 95% ee; 

 
D
20+0.8 (c 0.5, CH2Cl2) 
and lactam (3S,4S)-77 (95:5 dr) as a colourless oil (53.0 mg, 16%) with identical spectroscopic properties 
as before in 97% ee; 

 
D
20-6.8 (c 0.5, CH2Cl2). 
(3S,4R)-1-[(4-methylbenzene)sulfonyl]-4-phenyl-3-[(1Z)-prop-1-en-1-yl]azetidin-2-one 35 and 
(3S,4S)-1-[(4-methylbenzene)sulfonyl]-4-phenyl-3-[(1Z)-prop-1-en-1-yl]azetidin-2-one 78  
Following general procedure A, (Z)-pent-3-enoic acid 68 (160 mg, 1.60 mmol), iPr2NEt (420 L, 2.40 
mmol) and pivaloyl chloride (296 L, 2.40 mmol) in CH2Cl2 (10 mL), HBTM-2.1 (2S,3R)-23 (24.6 mg, 
0.08 mmol, 10 mol%), imine 19 (207 mg, 0.80 mmol) and iPr2NEt (348 L, 2.00 mmol) for 1.5 h at rt 
gave crude lactams (3S,4R)-35 and (3S,4S)-78 (48:52 dr). Chromatographic purification (eluent 
Et2O:petrol 20:80) gave lactam (3S,4R)-35 (92:8 dr) as a colourless oil (89 mg, 33%) and lactam (3S,4S)-
78 (88:12 dr) as a white solid (97 mg, 36%):  
Data for lactam (3S,4R)-35: Chiral HPLC Chiralpak AD-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) tR(3R,4S): 14.5 min, tR(3S,4R): 16.0 min, 92% ee; max (ATR)/cm
-1
 3030, 2967 (C-H), 1788 
(C=O), 1456, 1362 (S=O), 1167 (S=O); Data for major diastereoisomer: δH (500 MHz, CDCl3) 1.51 (3H, 
dd, J 6.9, 1.8 Hz, CH3CH=CH), 2.43 (3H, s, ArCH3), 4.00-4.02 (1H, m, C(3)H), 4.75 (1H, d, J 3.2 Hz, 
C(4)H), 5.44 (1H, ddq, J 10.6, 8.8, 1.8 Hz, CH3CH=CH), 5.78 (1H, dqd, J 10.7, 6.9, 1.4 Hz, 
CH3CH=CH), 7.23-7.25 (4H, m, ArH), 7.28-7.35 (3H, m, ArH), 7.62-7.65 (2H, m, SO2Ar(2,6)H); δC (125 
MHz, CDCl3) 14.0 (CH3CH=CH), 21.8 (ArCH3), 58.2 (C(3)), 64.4 (C(4)), 120.5 (CH3CH=CH), 126.7 
(C(4)ArC(3,5)), 127.6 (SO2ArC(3,5)), 128.9 (SO2ArC(2,6)), 129.1 (C(4)ArC(4)), 129.9 (C(4)ArC(2,6)), 
132.1 (CH3CH=CH), 135.7 (4ry ArC), 136.0 (4ry ArC), 145.3 (C(4)ArC(1)), 165.9 (C(2)=O); m/z (NSI) 
342 ([M+H]
+
, 42%); HRMS (NSI) C19H20NO3S
+
 ([M+H]
+
) requires 342.1158; found 342.1159 (+0.2 
ppm) 
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Data for lactam (3S,4S)-78: mp 83-85 °C: Chiral HPLC Chiralcel OD-H (10% IPA:hexane, flow rate 1 mL 
min
-1
, 211 nm, 30 °C) tR(3S,4S): 12.0 min, tR(3R,4R): 15.8 min, 98% ee; max (ATR)/cm
-1
 3032, 2922 (C-
H), 1788 (C=O), 1458, 1354 (S=O), 1165 (S=O); Data for minor diastereoisomer: δH (500 MHz, CDCl3) 
1.55-1.57 (3H, m, CH3CH=CH), 2.46 (3H, s, ArCH3), 4.47-4.50 (1H, m, C(3)H), 4.89-4.94 (1H, m, 
CH3CH=CH), 5.31 (1H, d, J 6.8 Hz, C(4)H), 5.54 (1H, dqd, J 10.8, 6.9, 1.5 Hz, CH3CH=CH), 7.09-7.11 
(2H, m, ArH), 7.23-7.34 (5H, m, ArH), 7.76-7.78 (2H, m, SO2Ar(2,6)H); δC (125 MHz, CDCl3) 13.9 
(CH3CH=CH), 21.9 (ArCH3), 53.7 (C(3)), 61.8 (C(4)), 118.6 (CH3CH=CH), 127.4 (C(4)ArC(3,5)), 127.8 
(SO2ArC(3,5)), 128.5 (SO2ArC(2,6)), 128.7 (C(4)ArC(4)), 130.0 (C(4)ArC(2,6)), 132.1 (CH3CH=CH), 
134.0 (4ry ArC), 135.7 (4ry ArC), 145.4 (C(4)ArC(1)), 165.9 (C(2)=O); m/z (NSI) 342 ([M+H]
+
, 30%); 
HRMS (NSI) C19H20NO3S
+
 ([M+H]
+
) requires 342.1158; found 342.1160 (+0.5 ppm) 
Reaction carried out for 1.5 h at −78 °C gave crude lactams (3S,4R)-35:(3S,4S)-78 (43:57 dr). 
Chromatographic purification (eluent Et2O:petrol 20:80) gave lactam (3S,4R)-35 (92:8 dr) as a colourless 
oil (58 mg, 21%) with identical spectroscopic properties as before in 99% ee; 

 
D
20
+4.2 (c 0.5, CH2Cl2) 
and lactam (3S,4S)-78 (88:12 dr) as a white solid (99.0 mg, 36%) with identical spectroscopic properties 
as before in 99% ee; 

 
D
20
-14.2 (c 0.5, CH2Cl2). 
(3S,4R)-4-phenyl-3-((E)-prop-1-en-1-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 36 
Following general procedure A, (E)-pent-3-enoic acid 24 (40.6 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (6.16 mg, 
0.02 mmol, 5 mol%), (E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one 57 (80.0 mg, 0.40 mmol) and iPr2NEt 
(174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-36 (88:12 dr). Chromatographic 
purification (eluent Et2O:petrol 4:96) gave lactone (3S,4R)-36 (88:12 dr) as a colourless oil (89.8 mg, 
80%); 

 
D
20
-212.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 1 mL min
-1
, 
211 nm, 30 °C) major diastereoisomer: tR(3S,4R): 9.7 min, tR(3R,4S): 13.2 min, 96% ee; minor 
diastereoisomer tR: 10.7 min, tR: 14.8 min, 15% ee; max (ATR)/cm
-1
 3060, 3027 (C-H), 1784 (C=O), 
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1699; Data for major diastereoisomer: δH (500 MHz, CDCl3) 1.68 (3H, t, J, 5.9, CH3), 3.43 (1H, t, J 6.9, 
C(3)H), 3.70-3.75 (1H, m, C(4)H), 5.44-5.56 (2H, m, C(3)CH=CHCH3 and C(3)CH=CHCH3), 6.09 (1H, 
d, J 4.5, C(5)H), 7.11 (2H, d, J 7.8, C(4)Ar(2,6)H), 7.31-7.40 (3H, m, C(4)Ar(3,5)H and C(4)Ar(4)H); δC 
(75 MHz, CDCl3) 18.1 (CH3), 43.2 (C(4)), 49.9 (C(3)), 109.7 (q, J 3.5, C(5)), 118.5 (q, J 270, CF3), 123.8 
(C(3)CH=CHCH3), 127.4 (ArC), 128.1 (ArC), 129.2 (ArC), 132.1 (C(3)CH=CHCH3), 138.7 (4ry 
C(4)ArC(1)), 140.8 (q, J 37.9, C(6)), 166.1 (C(2)); F (376 MHz, CDCl3) -72.6 (CF3); Selected data or 
minor diastereoisomer: δH (500 MHz, CDCl3) 3.63 (1H, t, J 7.8, C(3)H), 3.86-3.88 (1H, m, C(4)H), 5.13 
(1H, dd, J 15.4, 8.6, C(3)CH=CHCH3), 5.69 (1H, dq, J 14.7, 7.1, C(3)CH=CHCH3), 6.23 (1H, d, J 5.7, 
C(5)H), 7.11 (2H, d, J 7.7, Ar(2,6)H); δC (75 MHz, CDCl3) 18.0 (CH3), 43.0 (C(4)), 47.7 (C(3)), 110.8 (q, 
J 3.5, C(5)), 122.6 (C(3)CH=CHCH3), 128.2 (ArC), 128.3 (ArC), 129.1 (ArC), 132.2 (C(3)CH=CHCH3), 
166.6 (C(2)); F (376 MHz, CDCl3) -72.7 (CF3); m/z (NSI
+
) 300 ([M+NH4]
+
, 100%); HRMS (NSI
+
) 
C15H17F3NO2
+
 ([M+NH4]
+
) requires 300.1206; found 300.1206 (+0.0 ppm). 
(3S,4R)-4-phenyl-3-((E)-but-1-en-1-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 37 
Following general procedure A, (E)-hex-3-enoic acid 81 (47.4 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (6.16 mg, 
0.02 mmol, 5 mol%), (E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one 57 (80.0 mg, 0.40 mmol) and iPr2NEt 
(174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-37 (90:10 dr). Chromatographic 
purification (eluent Et2O:petrol 3:97) gave lactone (3S,4R)-37 (93:7 dr) as a colourless oil (98.7 mg, 83%); 

 
D
20
-191.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 1 mL min
-1
, 211 
nm, 30 °C) major diastereoisomer: tR(3S,4R): 8.9 min, tR(3R,4S): 12.4 min, 96% ee; minor 
diastereoisomer tR: 9.9 min, tR: 14.4 min, 12% ee; max (ATR)/cm
-1
 3065, 2968 (C-H), 1786 (C=O), 1699; 
Data for major diastereoisomer: δH (500 MHz, CDCl3) 0.92 (3H, t, J 7.5, CH3), 2.00-2.06 (2H, m, 
CH2CH3), 3.42 (1H, t, J 7.1, C(3)H), 3.71-3.74 (1H, m, C(4)H), 5.41-5.45 (1H, m, C(3)CH=CHCH2CH3 
or C(3)CH=CHCH2CH3), 5.49-5.54 (1H, m, C(3)CH=CHCH2CH3 or C(3)CH=CHCH2CH3), 6.10 (1H, d, 
J 4.6, C(5)H), 7.14-7.16 (2H, m, C(4)Ar(2,6)H), 7.31-7.40 (3H, m, C(4)Ar(3,5)H and C(4)Ar(4)H); δC 
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(125 MHz, CDCl3) 13.2 (CH3), 25.6 (CH2CH3), 43.3 (C(4)), 49.9 (C(3)), 109.7 (q, J 3.5, C(5)), 118.5 (q, J 
270, CF3), 121.6 (C(3)CH=CHCH2CH3), 127.5 (ArC), 128.1 (ArC), 129.2 (ArC), 138.7 (4ry C(4)ArC(1)), 
138.8 (C(3)CH=CHCH2CH3), 140.8 (q, J 37.9, C(6)), 166.2 (C(2)); F (376 MHz, CDCl3) -72.6 (CF3); 
Selected data or minor diastereoisomer: δH (500 MHz, CDCl3) 3.63 (1H, t, J 7.7, C(3)H), 3.87-3.90 (1H, 
m, C(4)H), 5.10 (1H, ddt, J 15.5, 8.5, 1.6, C(3)CH=CHCH2CH3), 5.70 (1H, dt, J 15.4, 6.4, 
C(3)CH=CHCH2CH3), 6.23 (1H, d, J 5.7, C(5)H), 7.11 (2H, d, J 8.0, Ar(2,6)H); δC (125 MHz, CDCl3) 
43.0 (C(4)), 47.6 (C(3)), 110.7 (q, J 3.5, C(5)), 120.5 (C(3)CH=CHCH2CH3), 128.2 (ArC), 128.2 (ArC), 
129.0 (ArC), 138.9 (C(3)CH=CHCH2CH3), 166.6 (C(2)); F (376 MHz, CDCl3) -72.6 (CF3); m/z (NSI
+
) 
297 ([M+H]
+
, 20%); HRMS (NSI
+
) C16H16F3O2
+
 ([M+H]
+
) requires 297.1097; found 297.1101 (+1.4 
ppm). 
(3S,4R)-4-phenyl-3-((E)-styryl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 38 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (64.9 mg, 0.40 mmol), iPr2NEt (104 L, 
0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (6.16 
mg, 0.02 mmol, 5 mol%), (E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one 57 (80.0 mg, 0.40 mmol) and 
iPr2NEt (174 L, 1.0 mmol) for 5 minutes at −78 °C gave crude lactone (3S,4R)-38 (95:5 dr). 
Chromatographic purification (eluent Et2O:petrol 7.5:92.5) gave lactone (3S,4R)-38 (95:5 dr) as a 
colourless oil (113 mg, 82%); 

 
D
20
-159.6 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% IPA:hexane, 
flow rate 1 mL min
-1
, 211 nm, 30 °C) major diastereoisomer: tR(3R,4S): 12.3 min, tR(3S,4R): 13.9 min, 
60% ee; minor diastereoisomer tR: 8.00 min, tR: 10.6 min, 52% ee; max (ATR)/cm
-1
 3063, 3030 (C-H), 
1782 (C=O), 1699, 1601; Data for major diastereoisomer: δH (500 MHz, CDCl3) 3.65 (1H, t, J 7.6, 
C(3)H), 3.85-3.90 (1H, m, C(4)H), 6.15-6.20 (2H, m, C(5)H and C(3)CH=CHPh), 6.36 (1H, d, J 15.9, 
C(3)CH=CHPh), 7.21 (2H, d, J 7.5, ArH), 7.28-7.42 (8H, m, ArH); δC (125 MHz, CDCl3) 43.3 (C(4)), 
50.0 (C(3)), 109.9 (q, J 3.3, C(5)), 118.5 (q, J 270, CF3), 122.0 (C(3)CH=CHPh), 126.6 (ArC), 127.5 
(ArC), 128.3 (ArC), 128.4 (ArC), 128.7 (ArC), 129.4 (ArC), 135.7 (C(3)CH=CHPh), 135.8 (4ry ArC), 
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138.5 (4ry ArC), 141.0 (q, J 38.0, C(6)), 165.6 (C(2)); F (376 MHz, CDCl3) -72.6 (CF3); Selected data or 
minor diastereoisomer: δH (500 MHz, CDCl3) 3.99 (1H, t, J 6.2, C(4)H), 5.84 (1H, dd, J 16.0, 8.6, 
C(3)CH=CHPh), 6.30 (1H, d, J 5.9, C(5)H), 6.59 (1H, d, J 16.0, C(3)CH=CHPh), 7.16 (2H, d, J 7.6, 
ArH); δC (125 MHz, CDCl3) 47.9 (C(3)), 110.7 (q, J 3.4, C(5)), 121.4 (C(3)CH=CHPh), 128.2 (ArC), 
128.5 (ArC), 129.3 (ArC), 135.4 (C(3)CH=CHPh), 166.2 (C(2)); F (376 MHz, CDCl3) -72.7 (CF3); m/z 
(NSI
+
) 345 ([M+H]
+
, 15%); HRMS (NSI
+
) C20H16F3O2
+
 ([M+H]
+
) requires 345.1097; found 345.1098 
(+0.3 ppm). 
(3S,4R)-4-(4-bromophenyl)-3-((E)-prop-1-en-1-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 
39 
Following general procedure A, (E)-pent-3-enoic acid 24 (40.6 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (6.16 mg, 
0.02 mmol, 5 mol%), (E)-1,1,1-trifluoro-4-(4-bromophenyl)-3-buten-2-one 58 (112 mg, 0.40 mmol) and 
iPr2NEt (174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-39 (80:20 dr). 
Chromatographic purification (eluent Et2O:petrol 3:97) gave lactone (3S,4R)-39 (95:5 dr) as a colourless 
oil (105 mg, 73%); 

 
D
20
-201.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralcel OD-H (1% IPA:hexane, flow rate 
1 mL min
-1
, 211 nm, 30 °C) major diastereoisomer: tR(3R,4S): 10.1 min, tR(3S,4R): 11.8 min, 92% ee; 
minor diastereoisomer tR: 9.3 min, tR: 12.8 min, 90% ee; max (ATR)/cm
-1
 2987 (C-H), 1786 (C=O), 1753, 
1660; Data for major diastereoisomer: δH (500 MHz, CDCl3) 1.69 (3H, t, J, 6.4, CH3), 3.37 (1H, t, J 7.4, 
C(3)H), 3.68-3.71 (1H, m, C(4)H), 5.43 (1H, ddd, J 15.3, 7.5, 1.3, C(3)CH=CHCH3), 5.52 (1H, dq, J 15.4, 
6.3, C(3)CH=CHCH3), 6.03 (1H, d, J 4.4, C(5)H), 7.02-7.04 (2H, m, C(4)Ar(3,5)H), 7.50-7.52 (2H, m, 
C(4)Ar(2,6)H); δC (125 MHz, CDCl3) 18.1 (CH3), 42.7 (C(4)), 49.7 (C(3)), 109.2 (q, J 3.5, C(5)), 118.4 
(q, J 270, CF3), 122.1 (C(4)ArC(4)), 123.4 (C(3)CH=CHCH3), 129.1 (C(4)ArC(3,5)), 132.3 
(C(4)ArC(2,6)), 132.6 (C(3)CH=CHCH3), 137.7 (4ry C(4)ArC(1)), 141.1 (q, J 38, C(6)), 165.8 (C(2)); F 
(376 MHz, CDCl3) -72.7 (CF3); Selected data or minor diastereoisomer: δH (500 MHz, CDCl3) 3.62 (1H, 
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t, J 7.8, C(3)H), 3.82-3.85 (1H, m, C(4)H), 5.09-5.14 (1H, m, C(3)CH=CHCH3), 5.65-5.72 (1H, m, 
C(3)CH=CHCH3), 6.18 (1H, d, J 5.7, C(5)H); δC (75 MHz, CDCl3) 18.0 (CH3), 44.4 (C(4)), 47.4 (C(3)); 
F (376 MHz, CDCl3) -72.8 (CF3); m/z (NSI
+
) 378 ([M+NH4]
+
, 56%); HRMS (NSI
+
) C15H16
78
BrF3NO2
+
 
([M+ NH4]
+
) requires 378.0311; found 378.0311 (+0.0 ppm). 
(3S,4R)-4-(thiophen-2-yl)-3-((E)-prop-1-en-1-yl)-6-(trifluoromethyl)-3,4-dihydro-2H-pyran-2-one 40 
Following general procedure A, (E)-pent-3-enoic acid 24 (40.6 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (6.16 mg, 
0.02 mmol, 5 mol%), (E)-1,1,1-trifluoro-4-(2-thienyl)-3-buten-2-one 59 (82.4 mg, 0.40 mmol) and 
iPr2NEt (174 L, 1.0 mmol) for 5 minutes at rt gave crude lactone (3S,4R)-40 (84:16 dr). 
Chromatographic purification (eluent Et2O:petrol 4:96) gave lactone (3S,4R)-40 (84:16 dr) as a colourless 
oil (95.8 mg, 83%); 

 
D
20
-187.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AS-H (0.5% IPA:hexane, flow 
rate 1 mL min
-1
, 211 nm, 30 °C) major diastereoisomer: tR(3S,4R): 14.1 min, tR(3R,4S): 16.1 min, 93% ee; 
max (ATR)/cm
-1
 2998 (C-H), 1784 (C=O), 1699, 1674; Data for major diastereoisomer: δH (300 MHz, 
CDCl3) 1.72-1.74 (3H, m, CH3), 3.55 (1H, td, J 6.7, 0.7, C(3)H), 4.00-4.04 (1H, m, C(4)H), 5.47 (1H, 
ddq, J 15.4, 8.4, 1.7, C(3)CH=CHCH3), 5.63-5.75 (1H, m, C(3)CH=CHCH3), 6.16 (1H, d, J 5.0, C(5)H), 
6.89-6.90 (1H, m, ArH), 6.98-7.03 (1H, m, ArH), 7.27-7.30 (1H, m, ArH); δC (125 MHz, CDCl3) 18.1 
(CH3), 38.2 (C(4)), 50.6 (C(3)), 109.2 (q, J 3.5, C(5)), 118.4 (q, J 270, CF3), 123.2 (C(3)CH=CHCH3), 
125.4 (ArC), 125.4 (ArC), 127.4 (ArC), 132.4 (C(3)CH=CHCH3), 140.7 (q, J 37.9, C(6)), 141.2 
(C(4)ArC(1)), 165.5 (C(2)); F (376 MHz, CDCl3) -72.4 (CF3); Selected data or minor diastereoisomer: δH 
(500 MHz, CDCl3) 3.64 (1H, t, J 7.5, C(3)H), 4.13-4.18 (1H, m, C(4)H), 5.35 (1H, ddq, J 15.4, 8.4, 1.7, 
C(3)CH=CHCH3), 6.28 (1H, d, J 5.8, C(5)H); δC (75 MHz, CDCl3) 18.1 (CH3), 38.0 (C(4)), 48.0 (C(3)), 
110.7 (q, J 3.5, C(5)), 122.5 (C(3)CH=CHCH3), 125.7 (ArC), 126.3 (ArC), 127.4 (ArC), 132.7 
(C(3)CH=CHCH3), 166.2 (C(2)); F (376 MHz, CDCl3) -72.6 (CF3); m/z (APCI
+
) 289 ([M+H]
+
, 100%); 
HRMS (APCI
+
) C13H12F3O2S
+
 ([M+H]
+
) requires 289.0505; found 289.0507 (+0.8 ppm). 
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(2R)-(E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)pent-3-enoate 41 
Following general procedure A, (E)-pent-3-enoic acid 24 (40.6 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 mg, 
0.004 mmol, 1 mol%), (NE)-N-(phenylimino)benzamide 60 (84.0 mg, 0.40 mmol) and iPr2NEt (174 L, 
1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, after 
chromatographic purification (eluent Et2O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-41 as a 
white solid (105 mg, 80%); mp 108-110 °C; 

 
D
20-67.0 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 13.2 min, tR(2R): 17.3 min, 96% ee; max 
(ATR)/cm
-1
 3350 (N-H), 2949 (C-H), 1721 (C=O), 1698 (C=O), 1597; Data for major rotamer: δH (500 
MHz, CDCl3) 1.72 (3H, d, J 4.7, CH3CH=), 3.78 (3H, s, OCH3), 5.25-5.26 (1H, m, C(2)H), 5.79-5.89 
(2H, m, CH=CHCH3 and CH=CHCH3), 6.94-6.97 (3H, m, NAr(2,6)H and NAr(4)H), 7.27-7.30 (2H, m, 
NAr(3,5)H), 7.50 (2H, t, J 7.6, C(O)Ar(3,5)H), 7.58 (1H, t, J 7.4, C(O)Ar(4)H), 7.86-7.88 (2H, m, 
C(O)Ar(2,6)H), 8.64 (1H, s, NH); δC (125 MHz, CDCl3) 18.2 (CH3CH=), 52.4 (OCH3), 64.6 (C(2)), 114.7 
(NArC(2,6)), 121.5 (NArC(4)), 123.6 (CH=CHCH3), 127.2 (C(O)ArC(2,6)), 128.8 (C(O)ArC(3,5)), 129.4 
(NArC(3,5)), 132.0 (C(O)ArC(4) or CH=CHCH3), 132.3 (C(O)ArC(4)) or CH=CHCH3), 133.0 (4ry 
C(O)ArC(1)), 148.1 (NArC(1)), 167.4 (NHC=O), 173.3 (MeOC=O);Selected data for minor rotamer: δH 
(500 MHz, CDCl3) 1.65 (3H, d, J 5.9, CH3CH=), 3.67 (3H, s, OCH3), 4.97 (1H, d, J 7.1, C(2)H); δC (125 
MHz, CDCl3) 18.1 (CH3CH=), 52.3 (OCH3), 65.8 (C(2)), 115.0 (NArC(2,6)); m/z (NSI
+
) 325 ([M+H]
+
, 
100%); HRMS (NSI
+
) C19H21N2O3
+
 ([M+H]
+
) requires 325.1547; found 325.1548 (+0.4 ppm). 
(2R)-(E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)hex-3-enoate 42 
Following general procedure A, (E)-hex-3-enoic acid 81 (47.4 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 mg, 
0.004 mmol, 1 mol%), (NE)-N-(phenylimino)benzamide 60 (84.0 mg, 0.40 mmol) and iPr2NEt (174 L, 
1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, after 
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chromatographic purification (eluent Et2O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-42 as a 
white solid (115 mg, 85%); mp 98-100 °C; 

 
D
20-54.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 11.3 min, tR(2R): 15.6 min, 99% ee; max 
(ATR)/cm
-1
 3352 (N-H), 2990 (C-H), 1721 (C=O), 1688 (C=O), 1597, 1508; Data for major rotamer: δH 
(500 MHz, CDCl3) 0.90 (3H, t, J 7.4, CH3CH2), 2.03-2.09 (2H, m, CH3CH2) 3.78 (3H, s, OCH3), 5.26-
5.27 (1H, m, C(2)H), 5.77-5.88 (2H, m, CH=CHCH2CH3 and CH=CHCH2CH3), 6.93-6.97 (3H, m, 
NAr(2,6)H and NAr(4)H), 7.26-7.29 (2H, m, NAr(3,5)H), 7.47-7.50 (2H, m, C(O)Ar(3,5)H), 7.55-7.58 
(1H, m, C(O)Ar(4)H), 7.85-7.87 (2H, m, C(O)Ar(2,6)H), 8.62 (1H, s, NH); δC (125 MHz, CDCl3) 13.1 
(CH3CH2), 25.6 (CH3CH2), 52.4 (OCH3), 64.5 (C(2)), 114.7 (NArC(2,6)), 121.6 (NArC(4) or 
CH=CHCH2CH3), 121.7 (NArC(4) or CH=CHCH2CH3), 127.3 (C(O)ArC(2,6)), 128.9 (C(O)ArC(3,5)), 
129.4 (NArC(3,5)), 132.1 (C(O)ArC(4)), 133.1 (C(O)ArC(1)), 138.8 (CH=CHCH2CH3), 148.2 (NArC(1)), 
167.4 (NHC=O), 173.4 (MeOC=O);Selected data for minor rotamer: δH (500 MHz, CDCl3) 3.67 (3H, s, 
OCH3), 4.99-5.00 (1H, m, C(2)H); δC (125 MHz, CDCl3) 12.5 (CH3CH2), 52.3 (OCH3), 66.1 (C(2)), 115.1 
(NArC(2,6)), 141.1 (CH=CHCH2CH3), 148.7 (NArC(1)), 167.4 (NHC=O), 173.4 (MeOC=O);m/z (NSI
+
) 
339 ([M+H]
+
, 100%); HRMS (NSI
+
) C20H23N2O3
+
 ([M+H]
+
) requires 339.1703; found 339.1708 (+1.4 
ppm). 
(2R)-(E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-5-methylhex-3-enoate 43 
Following general procedure A, (E)-5-methylhex-3-enoic acid 65 (51.2 mg, 0.40 mmol), iPr2NEt (104 L, 
0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 
mg, 0.004 mmol, 1 mol%), (NE)-N-(phenylimino)benzamide 60 (84.0 mg, 0.40 mmol) and iPr2NEt (174 
L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, after 
chromatographic purification (eluent Et2O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-43 as a 
white solid (104 mg, 74%); mp 128-130 °C; 

 
D
20
-66.6 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 14.5 min, tR(2R): 19.0 min, 99% ee; max 
 40 
(ATR)/cm
-1
 3326 (N-H), 2988 (C-H), 1719 (C=O Ester), 1678 (C=O Amide), 1597, 1506; Data for major 
rotamer: δH (500 MHz, CDCl3) 0.89 (3H, t, J 6.8, CH(CH3)CH3), 0.92 (3H, t, J 6.8, CH(CH3)CH3), 2.27-
2.34 (1H, m, CH(CH3)CH3), 3.78 (3H, s, OCH3), 5.27-5.28 (1H, m, C(2)H), 5.72-5.80 (2H, m, 
CH=CHCH(CH3)CH3 and CH=CHCH(CH3)CH3), 6.93-6.97 (3H, m, NAr(2,6)H and NAr(4)H), 7.26-7.30 
(2H, m, NAr(3,5)H), 7.46-7.49 (2H, m, C(O)Ar(3,5)H), 7.54-7.58 (1H, m, C(O)Ar(4)H), 7.85-7.88 (2H, 
m, C(O)Ar(2,6)H), 8.64 (1H, s, NH); δC (100 MHz, CDCl3) 21.8 (CH(CH3)CH3), 22.0 (CH(CH3)CH3), 
31.1 (CH(CH3)CH3), 52.3 (OCH3), 64.4 (C(2)), 114.8 (NArC(2,6)), 120.0 (CH=CHCH(CH3)CH3), 121.5 
(NArC(4)), 127.3 (C(O)ArC(2,6)), 128.8 (C(O)ArC(3,5)), 129.4 (NArC(3,5)), 132.1 (C(O)ArC(4)), 133.0 
(C(O)ArC(1)), 143.9 (CH=CHCH(CH3)CH3), 148.2 (NArC(1)), 167.3 (NHC=O), 173.4 (MeOC=O); 
Selected data for minor rotamer: δH (500 MHz, CDCl3) 3.66 (3H, s, OCH3), 5.01 (1H, d, J 7.0, C(2)H); δC 
(100 MHz, CDCl3)  21.4 (CH(CH3)CH3), 21.5 (CH(CH3)CH3), 31.1 (CH(CH3)CH3), 52.2 (OCH3), 66.3 
(C(2)), 115.2 (NArC(2,6)), 146.1 (CH=CHCH2CH3), 148.8 (NArC(1)), 172.0 (MeOC=O); m/z (NSI
+
) 353 
([M+H]
+
, 100%); HRMS (NSI
+
) C21H25N2O3
+
 ([M+H]
+
) requires 353.1860; found 353.1862 (+0.7 ppm). 
(2R)-(E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-5-phenylpent-3-enoate 44 
Following general procedure A, (E)-5-phenylpent-3-enoic acid 66
 
(70.4 mg, 0.40 mmol), iPr2NEt (104 L, 
0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 
mg, 0.004 mmol, 1 mol%), (NE)-N-(phenylimino)benzamide 60 (84.0 mg, 0.40 mmol) and iPr2NEt (174 
L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, after 
chromatographic purification (eluent Et2O:petrol 50:50) a rotameric mixture (ratio 96:4) of (2R)-44 as a 
white solid (123 mg, 77%); mp 136-138 °C; 

 
D
20
-70.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
IPA:hexane, flow rate 1 mL min
-1
, 220 nm, 30 °C) tR(2S): 28.5 min, tR(2R): 41.2 min, 99% ee; max 
(ATR)/cm
-1
 3323 (N-H), 2890 (C-H), 1730 (C=O Ester), 1686 (C=O Amide), 1599, 1514; Data for major 
rotamer: δH (500 MHz, CDCl3) 3.41 (2H, d, J 6.1, CHHPh and CHHPh), 3.78 (3H, s, OCH3), 5.34-5.35 
(1H, m, C(2)H), 5.89-6.00 (2H, m, CH=CHBn and CH=CHBn), 6.96-6.99 (3H, m, NAr(2,6)H and 
NAr(4)H), 7.05-7.03 (CH2Ar(2,6)H), 7.12-7.15 (CH2Ar(3,5)H and CH2Ar(4)H), 7.28-7.32 (2H, m, 
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NAr(3,5)H), 7.48-7.51 (2H, m, C(O)Ar(3,5)H), 7.58-7.62 (1H, m, C(O)Ar(4)H), 7.85-7.86 (2H, m, 
C(O)Ar(2,6)H), 8.68 (1H, s, NH); δC (100 MHz, CDCl3) 38.9 (CH2Ph), 52.4 (OCH3), 64.5 (C(2)), 114.7 
(NArC(2,6)), 121.6 (NArC(4)), 124.1 (CH=CHBn), 126.2 (CH2ArC(4)), 127.3 (C(O)ArC(2,6)), 128.4 
(ArC), 128.6 (ArC), 128.8 (C(O)ArC(3,5)), 129.4 (NArC(3,5)), 132.1 (C(O)ArC(4)), 132.8 (C(O)ArC(1)), 
135.7 (CH=CHBn), 138.9 (CH2ArC(1)), 148.1 (NArC(1)), 167.1 (NHC=O), 173.1 (MeOC=O); Selected 
data for minor rotamer δH (500 MHz, CDCl3) 3.67 (3H, s, OCH3), 5.06-5.08 (1H, m, C(2)H); δC (100 
MHz, CDCl3)  38.8 (CH2Ph), 52.3 (OCH3), 66.2 (C(2)), 115.2 (NArC(2,6)), 148.7 (NArC(1)); m/z (NSI
+
) 
401 ([M+H]
+
, 100%); HRMS (NSI
+
) C25H25N2O3
+
 ([M+H]
+
) requires 401.1860; found 401.1859 (-0.2 
ppm).
 
(2R)-(E)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)-4-phenylbut-3-enoate 45 
Following general procedure A, (E)-4-phenylbut-3-enoic acid 16 (64.9 mg, 0.40 mmol), iPr2NEt (104 L, 
0.60 mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 
mg, 0.004 mmol, 1 mol%), (NE)-N-(phenylimino)benzamide 60 (84.0 mg, 0.40 mmol) and iPr2NEt (174 
L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, after 
chromatographic purification (eluent Et2O:petrol 40:60) a rotameric mixture (ratio 95:5) of (2R)-45 as an 
off-white solid (109 mg, 71%); mp 116-118 °C; 

 
D
20
-19.6 (c 0.25, CH2Cl2); Chiral HPLC Chiralpak IB 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 22.0 min, tR(2R): 27.9 min, 91% ee; max 
(ATR)/cm
-1
 3325 (N-H), 3057, 2959 (C-H), 1728 (C=O), 1693 (C=O), 1599; Data for major rotamer: δH 
(500 MHz, CDCl3) 3.84 (3H, s, CH3), 5.50 (1H, d, J 5.1, C(2)H), 6.54 (1H, dd, J 16.3, 5.7, CH=CHPh), 
6.76 (1H, d, J 16.3, CH=CHPh), 6.99-7.04 (3H, m, ArH), 7.24-7.41 (7H, m, ArH), 7.44 (2H, t, J 8.7, 
C(O)Ar(3,5)H), 7.54 (1H, t, J 7.4, C(O)Ar(4)H), 7.83 (2H, d, J 7.4, C(O)Ar(2,6)H), 8.72 (1H, s, NH); δC 
(125 MHz, CDCl3) 52.6 (CH3), 64.9 (C(2)), 114.8 (NArC(2,6)), 121.7 (NArC(4)), 122.1 (CH=CHPh), 
126.8 (=CHArC(4)), 127.2 (C(O)ArC(2,6)), 128.3 (ArC), 128.7 (ArC), 128.8 (C(O)ArC(3,5)), 129.5 
NArC(3,5)), 132.1 (C(O)ArC(4)), 133.0 (C(O)ArC(1)), 135.0 (CH=CHPh), 135.9 (=CHArC(1)), 148.0 
(NArC(1)), 167.6 (NHC=O), 172.8 (MeOC=O); Selected data for minor rotamer: δH (500 MHz, CDCl3) 
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3.73 (3H, s, CH3), 5.21 (1H, d, J 7.2, C(2)H), 6.02 (1H, dd, J 16.1, 7.2, CH=CHPh), 7.98 (1H, s, NH); δC 
(125 MHz, CDCl3) 52.5 (CH3), 66.1 (C(2)), 115.1 (NArC(2,6)), 137.5 (CH=CHPh); m/z (NSI
+
) 387 
([M+H]
+
, 100%); HRMS (NSI
+
) C24H23N2O3
+
 ([M+H]
+
) requires 387.1703; found 387.1704 (-0.2 ppm). 
(2R)-(Z)-methyl 2-(2-benzoyl-1-phenylhydrazinyl)pent-3-enoate 46 
Following general procedure A, (Z)-pent-3-enoic acid 68 (40.0 mg, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 mg, 
0.004 mmol, 1 mol%), (NE)-N-(phenylimino)benzamide 60 (84.0 mg, 0.40 mmol) and iPr2NEt (174 L, 
1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, after 
chromatographic purification (eluent Et2O:petrol 50:50) a rotameric mixture (ratio 95:5) of (2R)-46 (94:6 
(Z):(E)) as a colourless oil (93.7 mg, 72%); 

 
D
20
-76.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak AD-H 
(20% IPA:hexane, flow rate 1 mL min
-1
, 220 nm, 30 °C) tR(2S): 19.1 min, tR(2R): 23.6 min, 99% ee; max 
(ATR)/cm
-1
 3291 (N-H), 2953 (C-H), 1732 (C=O Ester), 1674 (C=O Amide), 1599; Data for major isomer 
(Z) and major rotamer: δH (400 MHz, CDCl3) 1.88 (3H, dd, J 7.0, 1.8, CH3CH=), 3.75 (3H, s, OCH3), 5.48 
(1H, d, J 8.2, C(2)H), 5.61-5.67 (1H, m, CH=CHCH3), 5.91 (1H, dqd, J 10.7, 7.0, 1.0, CH=CHCH3), 
6.93-6.99 (3H, m, NAr(2,6)H and NAr(4)H), 7.26-7.30 (2H, m, NAr(3,5)H), 7.46-7.51 (2H, m, 
C(O)Ar(3,5)H), 7.54-7.59 (1H, m, C(O)Ar(4)H), 7.88-7.91 (2H, m, C(O)Ar(2,6)H), 8.67 (1H, s, NH); δC 
(100 MHz, CDCl3) 14.1 (CH3CH=), 52.6 (OCH3), 59.8 (C(2)), 114.7 (NArC(2,6)), 121.6 (NArC(4)), 
121.7 (CH=CHCH3), 127.4 (C(O)ArC(2,6)), 128.9 (C(O)ArC(3,5)), 129.5 (NArC(3,5)), 132.2 
(C(O)ArC(4), 132.7 (CH=CHCH3), 132.8 (C(O)ArC(1)), 148.3 (NArC(1)), 167.0 (NHC=O), 173.6 
(MeOC=O); m/z (NSI
+
) 325 ([M+H]
+
, 100%); HRMS (NSI
+
) C19H21N2O3
+
 ([M+H]
+
) requires 325.1547; 
found 325.1548 (+0.4 ppm). 
(2R)-(E)-methyl 2-(2-(4-fluorobenzoyl)-1-phenylhydrazinyl)pent-3-enoate 47 
Following general procedure A, (E)-pent-3-enoic acid 24 (40.6 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 mg, 
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0.004 mmol, 1 mol%), (NE)-4-fluoro-N-(phenylimino)benzamide 61 (91.2 mg, 0.40 mmol) and iPr2NEt 
(174 L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, 
after chromatographic purification (eluent Et2O:petrol 40:60) a rotameric mixture (ratio 92:8) of (2R)-47 
as a white solid (109 mg, 79%); mp 102-104 °C; 

 
D
20-57.8 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB 
(5% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 13.2 min, tR(2R): 17.1 min, 99% ee; max 
(ATR)/cm
-1
 3522 (N-H), 2951 (C-H), 1751 (C=O), 1661 (C=O), 1599; Data for major rotamer: δH (500 
MHz, CDCl3) 1.68-1.69 (3H, m, CH3CH=), 3.76 (3H, s, OCH3), 5.21-5.22 (1H, m, C(2)H), 5.74-5.84 (2H, 
m, CH=CHCH3 and CH=CHCH3), 6.91-6.95 (3H, m, NAr(2,6)H and NAr(4)H), 7.13-7.17 (2H, t, J 8.4, 
NAr(3,5)H), 7.24-7.27 (2H, m, C(O)Ar(3,5)H), 7.84-7.87 (2H, m, C(O)Ar(2,6)H), 8.60 (1H, s, NH); δC 
(125 MHz, CDCl3) 18.2 (CH3CH=), 52.4 (OCH3), 64.6 (C(2)), 114.8 (NArC(2,6)), 116.0 (d, J 21.8, 
C(O)ArC(3,5)), 121.7 (NArC(4)), 123.7 (CH=CHCH3), 129.2 (d, J 3.5, C(O)ArC(1)), 129.5 (NArC(3,5)), 
129.7 (d, J 8.7, C(O)ArC(2,6)), 132.4 (CH=CHCH3), 148.1 (NArC(1)), 165.2 (d, J 252, C(O)ArC(4)), 
166.4 (NHC=O), 173.4 (MeOC=O);F (376 MHz, CDCl3) -107.6 (ArF); Selected data for minor rotamer: 
δH (500 MHz, CDCl3) 1.61-1.62 (3H, m, CH3CH=), 3.65 (3H, s, OCH3), 4.95 (1H, d, J 7.3, C(2)H), 7.36 
(2H, dd, J 8.8, 7.4, C(O)Ar(3,5)H), 7.58-7.61 (2H, C(O)Ar(2,6)H); δC (125 MHz, CDCl3) 18.2 (CH3CH=), 
52.4 (OCH3), 66.0 (C(2)), 114.8 (NArC(2,6)); F (376 MHz, CDCl3) -108.8 (ArF); m/z (NSI
+
) 343 
([M+H]
+
, 100%); HRMS (NSI
+
) C19H20FN2O3
+
 ([M+H]
+
) requires 343.1452; found 343.1458 (+1.6 ppm). 
(2R)-(E)-methyl 2-(2-(furan-2-yl)-1-phenylhydrazinyl)pent-3-enoate 48 
Following general procedure A, (E)-pent-3-enoic acid 24 (40.6 L, 0.40 mmol), iPr2NEt (104 L, 0.60 
mmol) and pivaloyl chloride (74.0 L, 0.60 mmol) in CH2Cl2 (2 mL), HBTM-2.1 (2S,3R)-23 (1.23 mg, 
0.004 mmol, 1 mol%), (NE)-N-(phenylimino)furan-2-carboxamide 62 (80.0 mg, 0.40 mmol) and iPr2NEt 
(174 L, 1.00 mmol) for 15 min at rt, followed by addition of MeOH (2 mL) and stirring for 1 h at rt gave, 
after chromatographic purification (eluent Et2O:petrol 50:50) a rotameric mixture (ratio 94:6) of (2R)-48 
as a colourless oil (109 mg, 87%); 

 
D
20
-82.4 (c 0.5, CH2Cl2); Chiral HPLC Chiralpak IB (5% 
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IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) tR(2S): 16.0 min, tR(2R): 22.2 min, 99% ee; max 
(ATR)/cm
-1
 3335 (N-H), 2953 (C-H), 1730 (C=O), 1688 (C=O), 1589; Data for major rotamer: δH (500 
MHz, CDCl3) 1.70 (3H, dt, J 6.4, 1.3, CH3CH=), 3.76 (3H, s, OCH3), 5.20-5.21 (1H, m, C(2)H), 5.75 (1H, 
ddq, J 15.6, 6.0, 1.5, CH=CHCH3), 5.74 (1H, dqd, J 15.6, 6.4, 1.2, CH=CHCH3), 6.56 (1H, dd, J 3.5, 1.8, 
C(O)Ar(4)H), 6.92-6.95 (3H, m, NAr(2,6)H and NAr(4)H), 7.24-7.27 (3H, m, NAr(3,5)H and 
C(O)Ar(3)H), 7.52 (1H, dd, J 1.7, 0.8, C(O)Ar(5)H), 8.75 (1H, s, NH); δC (125 MHz, CDCl3) 18.2 
(CH3CH=), 52.4 (OCH3), 64.7 (C(2)), 112.2 (C(O)ArC(4)), 114.8 (NArC(2,6)), 115.9 (C(O)ArC(3)), 
121.6 (NArC(4)), 123.3 (CH=CHCH3), 129.4 (NArC(3,5)), 132.8 (CH=CHCH3), 144.7 (C(O)ArC(5)), 
146.6 (C(O)ArC(2)), 148.1 (NArC(1)), 158.2 (NHC=O), 173.0 (MeOC=O);Selected data for minor 
rotamer: δH (500 MHz, CDCl3) 3.69 (3H, s, OCH3), 5.10 (1H, d, J 7.1, C(2)H), 6.38 (1H, dd, J 3.5, 1.7, 
C(O)Ar(3)H); δC (125 MHz, CDCl3) 18.1 (CH3CH=), 52.4 (OCH3), 65.5 (C(2)), 111.6 (C(O)ArC(4)), 
115.0 (NArC(2,6)), 129.8 (NArC(3,5)), 145.6 (C(O)ArC(5)); m/z (NSI
+
) 315 ([M+H]
+
, 100%); HRMS 
(NSI
+
) C17H19N2O4
+
 ([M+H]
+
) requires 315.1339; found 315.1335 (-1.4 ppm). 
(3R,4R,5R)-N'-(4-hydroxy-5-methyl-2-oxooxolan-3-yl)-N'-phenylbenzohydrazide amine 49 and 
(3R,4S,5S)-N'-(4-hydroxy-5-methyl-2-oxooxolan-3-yl)-N'-phenylbenzohydrazide amine 50 
To a solution of hydrazide (2R)-41 (1.12 g, 3.44 mmol) in acetone:water (9:1, 40 mL) was added 2,6-
lutidine (0.80 mL, 6.88 mmol), N-methylmorpholine-N-oxide (0.60 g, 5.16 mmol) and OsO4 (4% wt in 
H2O, 0.44 mL, 0.07 mmol) and the reaction mixture was stirred at rt for 5 h after which time if was 
quenched by addition of sat. aq. Na2S2O3. The reaction mixture was extracted with EtOAc (x 3) and the 
combined organic fractions were washed with HCl (2M in H2O), dried (MgSO4), filtered and concentrated 
in vacuo to give a mixture of crude diols (2R,3R,4R)-49 and (2R,3S,4S)-50 which were used directly in the 
next reaction without purification. The crude reaction mixture was dissolved in CH2Cl2 (50 mL) and 
treated with p-toluenesulfonic acid (0.65 g, 3.44 mmol). The reaction mixture was stirred at rt for 2 h 
before being quenched by addition of H2O. The reaction mixture was extracted with CH2Cl2 (x 3) and the 
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combined organic fractions were dried (MgSO4), filtered and concentrated in vacuo to give crude lactones 
(3R,4R,5R)-49 and (3R,4S,5S)-50 (70:30 dr).  
Major diastereoisomer: Chromatographic purification (eluent Et2O:petrol 60:40 to 100% Et2O) gave 
lactone (3R,4R,5R)-49 (>99:1 dr) as a white solid (0.59 g, 53%); mp 58-60 °C; 

 
D
20+37.0 (c 0.5, 
CH2Cl2); Chiral HPLC Chiralcel OJ-H (10% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
tR(3S,4S,5S): 13.5 min, tR(3R,4R,5R): 19.3 min, 99% ee; max (ATR)/cm
-1
 3306 (N-H and O-H), 2980 (C-
H), 1767 (lactone C=O), 1661 (amide C=O), 1597; δH (500 MHz, CDCl3) 1.44 (3H, d, J 6.3, CH3), 4.73-
4.79 (3H, m, C(3)H, C(4)H and C(5)H), 5.02 (1H, br s, OH), 6.93-6.96 (3H, m, NAr(2,6)H and NAr(4)H), 
7.24 (2H, td, J 9.1, 1.7, NAr(3,5)H), 7.43-7.46 (2H, m, C(O)Ar(3,5)H), 7.58 (1H, tt, J 7.5, 1.4, 
C(O)Ar(4)H), 7.79-7.81 (2H, m, C(O)Ar(2,6)H), 8.58 (1H, br s, NH); δC (125 MHz, CDCl3) 14.9 (CH3), 
66.8 (C(3)), 69.3 (C(4)), 77.3 (C(5)), 114.7 (NArC(2,6)), 121.7 (NArC(4)), 127.6 (ArC), 129.0 (ArC), 
129.5 (ArC), 131.4 (C=OArC(1)), 133.0 (C=OArC(4)), 148.0 (NArC(1)), 168.8 (NHC=O), 172.0 
(MeOC=O); m/z (NSI
+
) 327 ([M+H]
+
, 86%); HRMS (NSI
+
) C18H19N2O4
+
 ([M+H]
+
) requires 327.1339; 
found 327.1345 (+1.7 ppm). 
Minor diastereoisomer: Chromatographic purification (eluent Et2O:petrol 60:40 to 100% Et2O) gave 
lactone (3R,4S,5S)-50 (>99:1 dr) as a white solid (0.28 g, 25%); mp 110-112 °C; 

 
D
20
-266.4 (c 0.5, 
CH2Cl2); Chiral HPLC Chiralpak IA (40% IPA:hexane, flow rate 1 mL min
-1
, 211 nm, 30 °C) 
tR(3S,4R,5R): 8.9 min, tR(3R,4S,5S): 14.8 min, 99% ee; max (ATR)/cm
-1
 3238 (N-H and O-H), 2938 (C-
H), 1776 (lactone C=O), 1668 (amide C=O), 1597, 1510; δH (500 MHz, CDCl3) 1.51 (3H, d, J 6.3, CH3), 
4.61-4.65 (2H, m, C(4)H and C(5)H), 4.76 (1H, d, J 4.3, C(3)H), 4.95 (1H, s, OH), 6.88 (2H, d, J 8.0, 
NAr(2,6)H), 6.97 (1H, t, J 7.4, NAr(4)H), 7.30 (2H, tt, J 7.2, 1.8, NAr(3,5)H), 7.48-7.51 (2H, m, 
C(O)Ar(3,5)H), 7.58-7.62 (1H, m, C(O)Ar(4)H), 7.89-7.91 (2H, m, C(O)Ar(2,6)H), 8.92 (1H, s, NH); δC 
(125 MHz, CDCl3) 13.9 (CH3), 67.7 (C(3)), 70.3 (C(4)), 79.4 (C(5)), 113.0 (NArC(2,6)), 121.5 (NArC(4)), 
127.6 (ArC), 129.1 (ArC), 129.8 (ArC), 131.4 (C=OArC(1)), 133.1 (C=OArC(4)), 147.3 (NArC(1)), 168.9 
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(NHC=O), 172.0 (MeOC=O); m/z (NSI
+
) 327 ([M+H]
+
, 100%); HRMS (NSI
+
) C18H19N2O4
+
 ([M+H]
+
) 
requires 327.1339; found 327.1346 (+2.0 ppm). 
(3R,4R,5R)-4-hydroxy-5-methyl-2-(phenylamino)dihydrofuran-2(3H)-one 79 
To a solution of lactone (3R,4R,5R)-49 (65.2 g, 0.20 mmol) in MeOH (2 mL) at −78 °C was added SmI2 
(0.1 M in THF, 6.00 mL, 0.60 mmol) and the reaction mixture was stirred at −78 °C for 10 minutes after 
which time if was quenched by addition of sat. aq. NaHCO3. The reaction mixture was extracted with 
EtOAc (x 3) and the combined organic fractions were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent Et2O:petrol 60:40) gave lactone (3R,4R,5R)-79 as a colourless oil 
(29.0 mg, 70%); 

 
D
20
+18.0 (c 0.1, CH2Cl2); max (ATR)/cm
-1
 3381 (N-H or O-H), 2986 (C-H), 1761 
(C=O), 1603, 1499; δH (500 MHz, CDCl3) 1.45 (3H, d, J 6.8, CH3), 2.74 (1H, d, J 4.9, OH or NH), 4.13 
(1H, s, OH or NH), 4.18-4.19 (1H, m, C(3)H), 4.41 (1H, td, J 7.0, 4.8, C(4)H), 4.73 (1H, app. quintet, J 
6.7, C(5)H), 6.80-6.85 (3H, m, NAr(2,6)H and NAr(4)H), 7.19-7.23 (2H, m, NAr(3,5)H); δC (125 MHz, 
CDCl3) 14.7 (CH3), 59.6 (C(3)), 74.9 (C(4)), 77.4 (C(5)), 114.1 (NArC(2,6)), 119.6 (NArC(4)), 129.6 
(NArC(3,5)), 146.8 (NArC(1)), 174.2 (C=O);m/z (NSI+) 208 ([M+H]+, 100%); HRMS (NSI+) 
C11H14NO3
+
 ([M+H]
+
) requires 208.0968; found 208.0968 (-0.1 ppm).  
(3R,4S,5S)-4-hydroxy-5-methyl-2-(phenylamino)dihydrofuran-2(3H)-one 80 
To a solution of lactone (3R,4S,5S)-50 (65.2 g, 0.20 mmol) in MeOH (2 mL) at −78 °C was added SmI2 
(0.1 M in THF, 6.00 mL, 0.60 mmol) and the reaction mixture was stirred at −78 °C for 10 minutes after 
which time if was quenched by addition of sat. aq. NaHCO3. The reaction mixture was extracted with 
EtOAc (x 3) and the combined organic fractions were dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (eluent Et2O:petrol 60:40) gave lactone (3R,4S,5S)-80 as a colourless oil 
(31.4 mg, 76%); 

 
D
20
-98.0 (c 0.1, CH2Cl2); max (ATR)/cm
-1
 3389 (N-H or O-H), 2982 (C-H), 1761 
(C=O), 1603, 1506; δH (400 MHz, CDCl3) 1.47 (3H, d, J 6.5, CH3), 2.76 (1H, br s, OH or NH), 4.08 (1H, 
d, J 4.4, C(3)H), 4.40 (1H, dd, J 4.4, 2.9, C(4)H), 4.58 (1H, qd, J 6.5, 2.9, C(5)H), 6.67-6.70 (2H, m, 
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NAr(2,6)H), 6.84 (1H, tt, J 7.4, 1.0, NAr(4)H), 7.16-7.21 (2H, m, NAr(3,5)H); δC (100 MHz, CDCl3) 13.8 
(CH3), 60.4 (C(3)), 69.8 (C(4)), 78.6 (C(5)), 114.2 (NArC(2,6)), 120.5 (NArC(4)), 129.6 (NArC(3,5)), 
146.0 (NArC(1)), 174.6 (C=O); m/z (NSI+) 208 ([M+H]+, 100%); HRMS (NSI+) C11H14NO3
+
 ([M+H]
+
) 
requires 208.0968; found 208.0968 (-0.1 ppm). 
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